CA2657109A1 - Coatings for medical devices comprising a therapeutic agent and a metallic material - Google Patents

Coatings for medical devices comprising a therapeutic agent and a metallic material Download PDF

Info

Publication number
CA2657109A1
CA2657109A1 CA002657109A CA2657109A CA2657109A1 CA 2657109 A1 CA2657109 A1 CA 2657109A1 CA 002657109 A CA002657109 A CA 002657109A CA 2657109 A CA2657109 A CA 2657109A CA 2657109 A1 CA2657109 A1 CA 2657109A1
Authority
CA
Canada
Prior art keywords
coating composition
stent
disposed
coating
sidewall structure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002657109A
Other languages
French (fr)
Inventor
Pu Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2657109A1 publication Critical patent/CA2657109A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/082Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30317The prosthesis having different structural features at different locations within the same prosthesis
    • A61F2002/30322The prosthesis having different structural features at different locations within the same prosthesis differing in surface structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0026Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in surface structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • A61L2300/608Coatings having two or more layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00Materials or methods for coatings medical devices
    • A61L2420/08Coatings comprising two or more layers

Abstract

The invention relates generally to an implantable medical device for delivering a therapeutic agent to the body tissue of a patient, and a method for making such a medical device. In particular, the invention pertains to an implantable medical device, such as an intravascular stent, having a coating comprising a first coating composition comprising a therapeutic agent and, optionally, a polymer; and a second coating composition comprising a metallic material.

Description

COATINGS FOR MEDICAL DEVICES COMPRISING
A THERAPEUTIC AGENT AND A METALLIC MATERIAL
FIELD OF THE INVENTION
[0001] The invention relates generally to implantable medical devices for delivering a therapeutic agent to the body tissue of a patient, and methods for making such medical devices. In particular, the invention pertains to implantable medical devices, such as intravascular stents, having a coating comprising a first coating composition comprising a therapeutic agent and a second coating composition comprising a metallic material.

BACKGROUND OF THE INVENTION
[0002] Medical devices have been used to deliver therapeutic agents locally to the body tissue of a patient. For example, intravascular stents comprising a therapeutic agent have been used to locally deliver therapeutic agents to a blood vessel.
Often such therapeutic agents have been used to prevent restenosis. Examples of stents comprising a therapeutic agent include stents that comprise a coating containing a therapeutic agent for delivery to a blood vessel. Studies have shown that stents having a coating with a therapeutic agent are effective in treating or preventing restenosis.
[0003] Even though medical devices having a coating with a therapeutic agent are effective in preventing restenosis, many coated medical devices, in addition to being coated with a therapeutic agent, are also coated'with a polymer. The benefits of using a polymer in such coatings include easier loading of therapeutic agents onto the surface of a medical device and the ability to control or regulate the rate of release of the therapeutic agent.
[0004] However, the use of polymers in medical device coatings can also have some disadvantages. For example, depending on the type of polymer used to coat the medical device, some polymers can cause inflammation of the body lumen, offsetting the effects of the therapeutic agent. Additionally, some polymers may also cause thrombosis.
[0005] Accordingly, there is a need for coatings for a medical device that prevent or at least reduce the disadvantages associated with polymer coatings, such as inflammation caused by contact with the body lumen. Moreover, there is a need for a coating for medical devices that can control or regulate the release rate of a therapeutic agent without the use of polymer coatings. There is also a need for methods of making such medical devices.
SUMMARY OF THE INVENTION
[0006] These and other objectives are accomplished by the present invention.
The present invention provides a medical device, such as an implantable, intravascular stent comprising a coating. The coating is designed to eliminate or at least reduce the amount of polymer contact with the body tissue, such as a body lumen, while still providing a suitable release rate of the therapeutic agent. The coating comprises a first coating composition comprising a therapeutic agent and a second coating composition comprising a metallic material. Optionally, the first coating composition can further comprise a polymer.
[0007] The coating can comprise a first coating composition comprising a therapeutic agent, disposed on the surface of a medical device; and a second coating composition, which comprises a metallic material and which is substantially free of any polymer, disposed on at least a portion of the first coating composition.
Metallic materials are materials containing a metal including but not limited to, metals alloys and oxides. As used herein and unless otherwise defined the phrase "substantially free of any polymer" means having less than or equal to 50% of polymer by volume of the composition. With such coatings, polymer contact with the body lumen is reduced or eliminated.
[0008] For example, the present invention is directed to an implantable intravascular stent comprising: (a) a stent sidewall structure having a surface; and (b) a coating comprising: (i) a first coating composition comprising a therapeutic agent disposed upon at least a portion of the surface of the stent sidewall structure, wherein the first coating composition, when disposed on the portion of the surface of the stent sidewall structure, has an outer surface; and (ii) a second coating composition comprising a metallic material disposed on at least a portion of the first coating composition, wherein the second coating composition is substantially free of any polymer when applied to the portion of the first coating composition; and wherein after the second coating composition is applied to the portion of the first coating composition the second coating composition comprises an outer surface and a plurality of pores, in which the pores extend from the outer surface of the first coating composition to the outer surface of the second coating composition. In certain embodiments of the present invention the second coating composition is disposed on less than the entire outer surface of the first coating composition. Additionally, the second coating composition can also be further disposed on a portion of the surface of the stent sidewall structure.
[0009) The stent sidewall structure can be an abluminal surface or an adluminal surface. In certain embodiments, the coating is disposed on at least a portion of the abluminal surface. In other embodiments, the first coating composition is disposed on at least a portion of the adluminal surface and the second coating composition is disposed on at least a portion of the first coating composition disposed on the adluminal surface.
In still other embodiments, the first coating composition is disposed on at least a portion of the adluminal surface and the adluminal surface is free of the second coating composition.
[0010) Additionally, the stent sidewall structure can comprise a plurality of struts wherein the surface of the stent sidewall structure is the abluminal surface or adluminal surface of at least one of the struts. When the stent sidewall structure comprises a plurality of struts, the coating can be disposed on at least a portion of the abluminal or adluminal surface of at least one of the struts. For exatnple, the present invention is directed to an implantable intravascular stent comprising: (a) a stent sidewall structure comprising a plurality of struts each having an ablurninal surface and an adluminal surface (b) a first coating disposed on the abluminal surface of at least one strut comprising: (i) a first coating composition comprising an anti-restenosis agent disposed upon at least a portion of the abluminal surface of the strut, wherein the first coating composition, when disposed on the portion of the surface of the abluminal surface of the strut, has an outer surface; and (ii) a second coating composition comprising a metallic material disposed on at least a portion of the first coating composition, wherein the second coating composition is substantially free of any polymer; and wherein after the second coating composition is applied to the portion of the first coating composition the second coating composition comprises an outer surface and a plurality of pores, in which the pores extend from the outer surface of the first coating composition to the outer surface of the second coating composition; and (c) a second coating disposed on at least a portion of the adluminal surface of the at least one strut comprising the first coating composition.
[0011) In certain embodiments, the first coating composition is disposed on at least a portion of the adluminal surface of at least one of the struts and at least a portion of the adluminal surface of at least one of the struts is free of the second coating composition.
In other embodiments, the first coating composition is disposed on at least a portion of the adluminal surface of at least one of the struts and the second coating composition is disposed on at least a portion of the first coating composition that is disposed on the adlum.inal surface.
[0012] In certain embodiments, the stent sidewall structure can further comprise a plurality of openings therein. When the stent sidewall structure has a plurality of openings, the first and second coating compositions can conform to the stent sidewall structure to preserve the openings in the stent sidewall structure. For example the present invention includes an implantable intravascular stent comprising: (a) a stent sidewall structure comprising (1) a plurality of struts each having an abluminal surface and an adluminal surface, and (2) openings in the stent sidewall structure;
(b) a first coating disposed on the abluminal surface of at least one strut comprising:
(i) a first coating composition comprising an anti-restenosis agent disposed upon at least a portion of the abluminal surface of the strut, wherein the first coating composition, when disposed on the portion of the surface of the abluminal surface of the strut, has an outer surface; and (ii) a second coating composition comprising a metallic material disposed on at least a portion of the first coating composition, wherein the second coating composition is substantially free of any polymer; and wherein after the second coating composition is applied to the portion of the first coating composition, the second coating composition comprises an outer surface and a plurality of pores, in which the pores extend from the outer surface of the first coating composition to the outer surface of the second coating composition; and (c) a second coating disposed on at least a portion of the adluminal surface of the at least one strut comprising the first coating composition, wherein the adluminal surface of the at least one strut is free of the second coating composition; and wherein the first and second coatings conform to the stent sidewall structure to preserve the openings therein.
[0013] Also the present invention is directed to an implantable intravascular stent comprising: (a) a stent sidewall structure having a surface; and (b) a coating comprising (i) a first coating composition comprising a therapeutic agent disposed upon at least a portion of the surface of the stent sidewall structure wherein the first coating composition has a first thickness; and (ii) a second coating composition comprising a metallic material disposed upon at least a portion of the surface of the stent sidewall structure, wherein the second coating composition has a second thickness and is substantially free of any polymer; and wherein the first thickness of the first coating composition is not greater than the second thickness of the second coating composition.
The first coating composition can also further comprise a polymer.
[0014] In certain embodiments, the second thickness of the second coating composition can be greater than the first thickness of the first coating composition.
Alternatively, the first thickness of the first coating composition can be equal to the second thickness of the second coating composition. Moreover, the second coating composition can be disposed adjacent to the first coating composition on the surface of the stent sidewall structure.
[0015] In any of the embodiments described above, the first thickness of the first coating composition can be about 1 micron to about 30 microns and the second thickness of the second coating composition can be about 0.1 microns to about microns.
[0016] The therapeutic agent in the first coating composition can comprise an agent that inhibits smooth muscle cell proliferation. The therapeutic agent in the first coating composition can also comprise an anti-thrombogenic agent, anti-angiogenesis agent, anti-proliferative agent, antibiotic, anti-restenosis agent, growth factor, immunosuppressant or radiochemical. For example the therapeutic agent can comprise paclitaxel, sirolimus, tacrolimus, pimecrolimus, everolimus or zotarolimus.
[0017] Additionally, the first coating composition further comprises at least one polymer. Suitable polymers include, but are not limited to, styrene-isobutylene copolymers, polylactic acid and poly(methylmethacrylate-butyl acrylate-methyl methacrylate). ' [0018] The metallic material of the second coating composition can be selected from the group consisting of stainless steel, nickel, titanium, chromium and alloys thereof.
BRIEF DESCRIPTION OF THE DRAWINGS
[0019] The present invention will be explained with reference to the following drawings.
[0020] Figure 1 shows a cross-sectional view of an embodiment of a coating disposed on at least a portion of a medical device.
[0021] Figure 2 shows a cross-sectional view of another embodiment of a coating disposed on at least a portion of a medical device.
[0022] Figure 3 shows a portion of a medical device that is suitable for use in the present invention.
[0023] Figure 4 shows a cross-sectional view of a stent.

10024] Figure 4a shows a cross-sectional view of a strut of a stent having a coating thereon.
[0025] Figure 4b shows a cross-sectional view of another embodiment of a strut of a stent having a coating thereon.
[0026] Figure 5 shows a perspective view of an embodiment of a coating disposed on at least a portion of a stent.
[0027] Figure 6 shows a perspective view of another embodiment of a coating disposed on at least a portion of a stent.
[0028] Figure 7 shows a perspective view of yet another embodiment of a coating disposed on at least a portion of a stent.
[0029] Figure 8 shows a perspective view of yet another embodiment of a coating disposed on at least a portion of a stent.
[0030] Figure 9 shows a cross-sectional view of another embodiment of a coating disposed on at least a portion of a medical device.
[0031] Figure 10 shows a cross-sectional view of yet another embodiment of a coating disposed on at least a portion of a medical device.
[0032] . Figure 11 shows a cross-sectional view of yet another embodiment of a coating disposed on at least a portion of a medical device.

DETAILED DESCRIPTION
[0033] The present invention is directed to a medical device comprising a coating comprising a first coating composition containing a therapeutic agent and optionally a polymer. The medical device also includes a second coating composition containing a metallic material and is substantially free of any polymer.
[0034] In certain embodiments, the coating comprises a first coating composition comprising a therapeutic agent disposed on the surface of the medical device and a second coating composition comprising a metallic material disposed on the first coating composition. The second coating composition is substantially free of any polymer.
Also, after the second coating composition is disposed on the first coating composition, wherein the second coating composition comprises a plurality of pores that extend from the outer surface of the first composition to the outer surface of the second coating composition.
[0035] Figure 1 shows a cross-sectional view an embodiment of a coating disposed on at least a portion of a medical device such as a stent. In this embodiment, inedical device 10 has a surface 12 and a coating 20. Coating 20 includes a first coating composition 22 comprising a therapeutic agent 30 disposed on at least a portion of the surface 12 of the rriedical device 10. When disposed on the surface 12, the first coating composition 22 has an outer surface 22a. The coating also includes a second coating composition 24 disposed on at least a portion of the first coating composition 22. The second coating composition 24 comprises a metallic material and is substantially free of any polymer. The second coating composition 24 can be disposed on a portion of or the entire first coating composition 22.
[0036] As shown in Figure 1, the second coating composition 24 after being applied to the first coating composition 22 has an outer surface 24a and also has a plurality of pores 42. At least some of the pores 42 extend from the outer surface 22a of the first coating composition 22 to the outer surface 24a of the second coating composition 24.
The pores 42 can be partially or completely filled with the first coating composition 22.
In either case having the pores that extend from the outer surface 22a of the first coating composition 22 to the outer surface 24a of the second coating composition 24 allows the therapeutic agent 30 to be released from the first coating composition 22 underlying the second coating composition 24. Additionally, having pores 42 that allow for fluid communication between the outer surfaces 22a and 24a can aid in vascularization, provide long term non-inflammation and minimize or eliminate thrombosis.
Furthermore, some or all of the pores 42 in the second coating composition 24 can be interconnected to other pores 42 within the second coating composition 24. In some embodiments, the pores 42 may be disposed in a desired pattern.
[0037] In addition, the pores 42 in the second coating composition 24 may have any shape. For example, the pores 42 can be shaped like channels, void pathways or microscopic conduits, spheres or hemispheres. Additionally, the pores 42 in the second coating composition 24 may have any size or range of sizes. In some instances, the pores 42 can be micropores or nanopores. Also, in some embodiments, it may be preferable that the width or diameter of the pores 42 is between about 1 nm and about pm.
[0038] The size of the pores 42 can also be used to control the release rate of the therapeutic agent 30. For example, pores 42 having a larger width will allow the therapeutic agent 30 to be released more quickly than pores 42 with a smaller width.
Also, the number of pores 42 in the second coating composition 24 can be adjusted to better control the release rate of the therapeutic agent 30. For example, the presence of more pores 42 per unit volume or weight of the second coating composition 24 can allow for a higher release rate of the therapeutic agent 30 than a material having fewer pores 42 therein.
[0039] In other embodiments, the coating comprises a first coating composition comprising a therapeutic agent and a polymer disposed on the surface of a medical device and a second coating composition comprising a metallic material disposed on the first coating composition. The second coating composition is substantially free of any polymer. Also, the after the second coating composition is disposed on the first coating composition, the second coating composition comprises a plurality of pores that extend from the outer surface of the first composition to the outer surface of the second coating composition.
100401 Figure 2 shows a cross-sectional view of another embodiment of a coating disposed on at least a portion of a surface of a medical device. In this embodiment medical device 10 has a surface 12 and a coating 20. Coating 20 has a first coating composition 22 comprising a therapeutic agent 30 and a polymer 32 disposed on the surface 12 of the medical device 10. The first coating composition 22 when disposed on the surface 12 has an outer surface 22a. A second coating composition 24 comprising a metallic material 40 is disposed on at least a portion of the first coating composition 22.
As shown in Figure 2, the second coating composition 24, when applied on the first coating composition 22, has an outer surface 24a and a plurality of pores 42.
Like Figure 1, the pores 42 extend from the outer surface 22a of the first coating composition 22 to the outer surface 24a of the second coating composition 24.
[0041] As shown in Figures 1 and 2, the first and second coating compositions can be disposed on the surface of a medical device in the form of layers. The coating can comprise one layer of each of the first and second coating compositions, as shown in Figures 1 and 2. However, more than one layer of each of the first and second coating compositions can be disposed on the surface of a medical device.
[0042] In other embodiments, the first coating composition disposed on the surface of medical device in a layer can have a thickness of about I micron to about 30 microns or about 1 micron to about 10 microns. Preferably, the first coating composition can have a thickness of about 3 microns to about 15 microns or about 0.8 microns to about 3.5 microns. In some instances, a relatively thicker layer may be preferred to incorporate greater amounts of the therapeutic agent. In addition, a relatively thicker layer may allow a greater amount of a therapeutic agent to be released over time.

[0043] The second coating composition comprising a metallic material, when disposed on the first coating composition, can have a thickness of about 0.1 micron to about.30 microns. Preferably, the second coating composition comprising a metallic material, when disposed on the first coating composition, can have a thickness of about 1 micron to about 10 microns. In addition, a relatively thicker film may allow the therapeutic agent to be released more slowly over time.
[0044] For the second coating composition, suitable metallic materials include any material that includes a metal such as, but not limited to metals, metal alloys or metal oxides that are biocompatible. Such metallic materials include, but are not limited to, metals and alloys based on titanium (such as nitinol, nickel titanium alloys, thermo-memory alloy materials); stainless steel; tantalum; tungsten; molybdenum;
nickel-chrome; or certain cobalt alloys including cobalt-ckiromium-nickel alloys such as Elgiloy and Phynox ; PERSS (Platinum EnRiched Stainless Steel) and Niobium.
Metallic materials also include clad composite filaments, such as those disclosed in WO 94/16646. Preferred, metallic materials include, platinum enriched stainless steel and zirconium and niobium alloys. Additionally, combinations of more than one metal or alloy can be used in the coatings of the present invention.
[0045] In some embodiments, the metallic material comprises at least 5%, at least 10%, at least 20%, at least 30 fo, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% or more by weight of the second coating composition. Preferably, the metallic material is about 1% to about 80%
by weight of the first coating composition. More preferably, the metallic material is about 50% to about 100% by weight of the second coating composition.
[0046] The second coating composition is substantially free of any polymer, i.e.
contains less than about 50% of polymer by weight of the second coating composition.
In some embodiments, the second coating composition is free of any polymer.
[0047] The coating can be disposed on the entire surface of the medical device or the coating can be disposed on a portion of the medical device. For example, if a medical device, such as a stent, that has an abluminal surface, i.e. the surface that contacts the body tissue, and an adluminal surface i.e. the surface that faces the lumen of the stent and is opposite the abluminal surface, the coating can be disposed on the abluminal surface while the adluminal surface can be free of the coating.
[0048] Figure 3 shows an example of a portion of a stent that is suitable for use in the present invention that has an abluminal and adluminal surface. Figure 3 shows an implantable intravascular stent 50 comprising a sidewall 52 which comprises a plurality of struts 60 and openings 55 in the sidewa1152. Generally, the openings 55 are disposed between adjacent struts 60. Also, the sidewa1152 may have a first sidewall surface 56 and an opposing second sidewall surface, which is not shown in Figure 3. The first sidewall surface 56 can be an abluminal surface or outer sidewall surface, which faces the body tissue when the stent is implanted, or an adlurninal surface or inner sidewall surface, which faces away from the body tissue. Likewise, the second sidewall surface can be an abluminal surface or an adluminal surface.
[00491 In certain embodiments, when the medical device, such as a stent, has a sidewall structure with openings therein it is preferable that the first coating composition and second coating composition disposed on the surface medical device, conform to the sidewall structure of the medical device so that the openings in the sidewall structure are preserved, e.g. the openings are not entirely or partially occluded with coating material.
[0050] Figure 4 shows a cross-sectional view of an intravascular stent 100 that comprises a plurality of struts 105 and a lumen 130. The struts 105 each comprise an abluminal surface 110, which faces away from the lumen 130, and contact the body tissue, such as a blood vessel, when the stent 100 is implanted. The struts 105 each comprise an adluminal surface 120, which faces the lumen 130 when the stent 100 is implanted.
[0051] Figures 4a and 4b show two embodiments where the struts of the stent of Figure 4 include the coatings of the present invention. In particular, Figure 4a shows an embodiment where the first coating composition 22 is disposed on at least a portion of the abluminal surface 12a and the adluminal surface 12b of a strut 105. The first coating composition 22 comprises a therapeutic agent 30 and optionally a polymer. A
second coating composition 24 comprising a metallic materia140 is disposed on at least a portion of the first coating composition 22 that is disposed on the abluminal surface 12a and the adluminal surface 12b of the strut 105. The second coating composition 24 when applied on the first coating composition 22 has an outer surface 24a and a plurality of pores 42. The pores 42 extend from the outer surface 22a of the first coating composition 22 to the outer surface 24a of the second coating composition 24.
[0052] Figure 4b shows an embodiment where the first coating composition 22 is disposed on at least a portion of the abluminal surface 12a and the adluminal surface 12b of a strut 105. The first coating composition 22 comprises a therapeutic agent 30 and optionally a polymer. A second coating composition 24 comprising a metallic material 40 is disposed only on at least a portion of the first coating composition 22 that is disposed on the abluminal surface 12a. The second coating composition 24 is not disposed on the portion of the first coating composition 22 that is disposed on the adluminal surface 12b of the strut 105. Like Figure 4a, the second coating composition 24 when applied on the first coating composition 22 has an outer surface 24a and a plurality of pores 42. The pores 42 extend from the outer surface 22a of the first coating composition 22 to the outer surface 24a of the second coating composition 24.
[0053] The second coating composition can be disposed completely over the first coating composition or the second coating composition can be disposed over a portion of the first coating composition. Additionally the second coating composition can be disposed on the first coating composition in any configuration such as, rings, bands, stripes or dots.
[0054] Figure 5 shows a perspective view of a round stent strut 200 comprising a surface 205 and a coating 210. Coating 210 is disposed on surface 205. Coating comprises a first coating composition 215 comprising a therapeutic agent 220 and a polymer 225 disposed on surface 205 and a second coating composition 230 comprising a metallic material 240 disposed on the first coating composition 215. In this embodiment, the second coating composition 230 is disposed on the first coating composition 215 in the configuration of rings 250.
[0055] Figure 6 shows a perspective view of a square-shaped stent strut 300 comprising a surface 305 and a coating 310. Coating 310 is disposed on surface 305.
Coating 310 comprises a first coating composition 315 comprising a therapeutic agent 320 and a polymer 325 disposed on surface 305 and a second coating composition comprising a metallic material 340 with pores as discussed above, disposed on the first coating composition 315. In this embodiment, the second coating composition 330 is disposed on the first coating composition 315 in the configuration of bands 350.
[0056] In another embodiment, second coating composition can be in the configuration of parallel bands or stripes. Figure 7 shows a stent strut 400 comprising a surface 405 and a coating 410. Coating 410 is disposed on surface 405. Coating comprises a first coating composition 415 comprising a therapeutic agent 420 and a polymer 425 disposed on surface 405 and a second coating composition 430 comprising a metallic materia1440 with pores as discussed above, disposed on the first coating composition 415. In this embodiment, the second coating composition 430 is disposed on the first coating composition 415 in the configuration of parallel bands or stripes 450.

[0057] Figure 8 shows a stent strut 500 comprising a surface 505 and a coating 510.
Coating 510 is disposed on surface 505. Coating 510 comprises a first coating composition 515 comprising a therapeutic agent 520 and a polymer 525 disposed on surface 505 and a second coating composition 530 comprising a metallic material 540 with pores as discussed above, disposed on the first coating composition 515.
In this embodiment, the second coating composition 530 is disposed on the first coating composition 515 in the configuration of wavy bands or stripes 550.
[0058] Figures 5-8 show some examples of configurations of the first coating composition and the second coating composition; however, other configurations of the first coating composition and the second coating composition can be used.
[0059] Also, in some embodiments, the second coating composition can be disposed on the first coating composition, as well as, the surface of the medical device. Figure 9 shows a cross-section view of another embodiment of a coating disposed on at least a portion of a medical device. In this embodiment medical device 600 has a surface 605 and coating 610 is disposed on surface 605 of medical device 600. Coating 610 includes a first coating composition 615 comprising a therapeutic agent 620 and optionally a polymer that is disposed on portions of the surface 605 of medical device 600.
A
second coating composition 630 comprising a metallic materia1640 is disposed on the first coating composition 615, as well as on at least a portion of the surface 605 of the medical device 600. As shown in Figure 9, the second coating composition 630 when disposed on the first coating composition 615 has an outer surface 630a and a plurality of pores 642. The pores 642 extend from the outer surface 615a of the first coating composition 615 to the outer surface 630a of the second coating composition 630.
[0060] In still other embodiments, the coating can comprise a first coating composition comprising a therapeutic agent and optionally a polymer disposed on the surface of a medical device, such as an implantable, intravascular stent and second coating composition comprising a metallic material also disposed on the surface of the medical device. Figure 10 shows a cross-sectional view of an embodiment of a coating disposed on at least a portion of a medical device. In this embodiment medical device 700 has a surface 705 and a coating 710 disposed on the surface 705 of the medical device 700. Coating 710 includes a first coating composition 715 comprising a therapeutic agent 720 and optionally a polymer disposed on the surface 705 of the medical device 700. The coating 710 also includes a second coating composition comprising a metallic materia1740 that is also disposed on the surface 705 of the medical device 700. The second coating composition 730 is substantially free of any polymer. In some embodiments, the second coating composition 730 when applied to the surface 705 can but need not include the pores described above. As shown in Figure 10, when disposed on the surface 705, both the first coating composition 715 and second coating composition 730 can have the same thickness, h.
100611 Alternatively, as shown in Figure 11, the thicknesses of the first coating composition 715 and the second coating composition 730 when disposed on the surface 705 of the medical device 700 can be different. As shown in Figure 11, coating 710 has a first coating composition 715 comprising a therapeutic agent 720 and a polymer 725 and a second coating composition 730 comprising a metallic material 740. When the first coating composition 715 comprises a polymer 725, it may be preferable for the thickness, x, of the second coating composition 730 to be greater than the thickness, y, of the first coating composition 715. Having the thickness x of the second coating composition 730, which is substantially free of any polymer, greater than that of the thickness y of the first coating composition prevents the polymer 725 in the first coating composition 715 from contacting the body lumen. This may eliminate possible adverse effects to the body lumen caused by contact with a polymer.

A. Medical Devices [0062] Suitable medical devices for the present invention include, but are not limited to, stents, surgical staples, cochlear implants, embolic coils, catheters, such as central venous catheters and arterial catheters, guidewires, cannulas, cardiac pacemaker leads or lead tips, cardiac defibrillator leads or lead tips, implantable vascular access ports, blood storage bags, blood tubing, vascular or other grafts, intra-aortic balloon pumps, heart valves, cardiovascular sutures, total artificial hearts and ventricular assist pumps, extra-corporeal devices such as blood oxygenators, blood filters, hemodialysis units, hemoperfusion units or plasmapheresis units.
100631 Medical devices which are particularly suitable for the present invention include any stent for medical purposes, which are known to the skilled artisan. Suitable stents include, for example, vascular stents such as self-expanding stents, balloon expandable stents and sheet deployable stents. Examples of self-expanding stents are illustrated in U.S. Patent Nos. 4,655,771 and 4,954,126 issued to Walisten and 5,061,275 issued to Wallsten et al. Examples of appropriate balloon-expandable stents are shown in U.S. Patent No. 5,449,373 issued to Pinchasik et al. In preferred embodiments, the stent suitable for the present invention is an Express stent.
More preferably, the Express stent is an ExpressTM stent or an Express2TM stent (Boston Scientific, Inc. Natick, Mass.).
[0064] The framework of the suitable stents may be formed through various methods as known in the art. The framework may be welded, molded, laser cut, electro-formed, or consist of filaments or fibers which are wound or braided together in order to form a continuous structure.
[0065] Medical devices that are suitable for the present invention may be fabricated from metallic, ceramic, polymeric or composite materials or a combination thereof.
Preferably, the materials are biocompatible. Metallic material is more preferable.
Suitable metallic materials include metals and alloys based on titanium (such as nitinol, nickel titanium alloys, thermo-memory alloy materials); stainless steel;
tantalum, nickel-chrome; or certain cobalt alloys including cobalt-chromium-nickel alloys such as Elgiloyg and Phynox ; PERSS (Platinum EnRiched Stainless Steel) and Niobium.
Metallic materials also include clad composite filaments, such as those disclosed in WO
94/16646. Preferred, metallic materials include, platinum enriched stainless steel and zirconium and niobium alloys.
[00661 Suitable ceramic materials include, but are not limited to, oxides, carbides, or nitrides of the transition elements such as titanium, hafnium, iridium, chromium, aluminum, and zirconium. Silicon based materials, such as silica, may also be used.
[0067] Suitable polymeric materials for forming the medical devices may be biostable. Also, the polymeric material may be biodegradable. Suitable polymeric materials include, but are not limited to, styrene isobutylene copolymers, polyetheroxides, polyvinyl alcohol, polyglycolic acid, polylactic acid, polyamides, poly-2-hydroxy-butyrate, polycaprolactone, poly(lactic-co-clycolic)acid, and Teflon.
[0068] Polymeric materials may be used for forming the medical device in the present invention include without limitation isobutylene-based polymers, polystyrene-based polymers, polyacrylates, and polyacrylate derivatives, vinyl acetate-based polymers and its copolymers, polyurethane and its copolymers, silicone and its copolymers, ethylene vinyl-acetate, polyethylene terephtalate, thermoplastic elastomers, polyvinyl chloride, polyolefins, cellulosics, polyamides, polyesters, polysulfones, polytetrafluorethylenes, polycarbonates, acrylonitrile butadiene styrene copolymers, acrylics, polylactic acid, polyglycolic acid, polycaprolactone, polylactic acid-polyethylene oxide copolymers, cellulose, collagens, and chitins.

[0069) Other polymers that are useful as materials for medical devices include without limitation dacron polyester, poly(ethylene terephthalate), polycarbonate, polymethylmethacrylate, polypropylene, polyalkylene oxalates, polyvinylchloride, polyurethanes, polysiloxanes, nylons, poly(dimethyl siloxane), polycyanoacrylates, polyphosphazenes, poly(amino acids), ethylene glycol I dimethacrylate, poly(methyl methacrylate), poly(2-hydroxyethyl methacrylate), polytetrafluoroethylene poly(HEMA), polyhydroxyalkanoates, polytetrafluorethylene, polycarbonate, poly(glycolide-lactide) co-polymer, polylactic acid, poly(y-caprolactone), poly(y -hydroxybutyrate), polydioxanone, poly(y -ethyl glutamate), polyiminocarbonates, poly(ortho ester), polyanhydrides, alginate, dextran, chitin, cotton, polyglycolic acid, polyurethane, or derivatized versions thereof, i.e., polymers which have been modified to include, for example, attachment sites or cross-linking groups, e.g., RGD, in which the polymers retain their structural integrity while allowing for attachment of cells and molecules, such as proteins, nucleic acids, and the like.
[0070] Medical devices may also be made with non-polymeric materials. Examples of useful non-polymeric materials include sterols such as cholesterol, stigmasterol, 0-sitosterol, and estradiol; cholesteryl esters such as cholesteryl stearate;
C1a-Ca4 fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, behenic acid, and lignoceric acid; C18-C36 mono-, di- and triacylglyceridcs such as glyceryl monooleate, glyceryl monolinoleate, glyceryl monolaurate, glyceryl monodocosanoate, glyceryl monomyristate, glyceryl monodicenoate, glyceryl dipalmitate, glyceryl didocosanoate, glyceryl dimyristate, glyceryl didecenoate, glyceryl tridocosanoate, glyceryl trimyristate, glyceryl tridecenoate, glycerol tristearate and mixtures thereof; sucrose fatty acid esters such as sucrose distearate and sucrose palmitate; sorbitan fatty acid esters such as sorbitan monostearate, sorbitan monopalmitate and sorbitan tristearate; C16-Ci$ fatty alcohols such as cetyl alcohol, myristyl alcohol, stearyl alcohol, and cetostearyl alcohol; esters of fatty alcohols and fatty acids such as cetyl palmitate and cetearyl palmitate; anhydrides of fatty acids such as stearic anhydride; phospholipids including phosphatidylcholine (lecithin), phosphatidylserine, phosphatidylethanolamine, phosphatidylinositol, and lysoderivatives thereof; sphingosine and derivatives thereof; sphingomyelins such as stearyl, palmitoyl, and tricosanyl sphingomyelins; ceramides such as stearyl and palmitoyl ceramides;
glycosphingolipids; lanolin and lanolin alcohols; and combinations and mixtures thereof, Non-polymeric materials may also include biomaterials such as stem sells, which can be seeded into the medical device prior to implantation. Preferred non-polymeric materials include cholesterol, glyceryl monostearate, glycerol tristearate, stearic acid, stearic anhydride, glyceryl monooleate, glyceryl monolinoleate, and acetylated monoglycerides.

B. Therapeutic Agents [0071] The term "therapeutic agent" as used in the present invention encompasses drugs, genetic materials, and biological materials and can be used interchangeably with "biologically active material". In one embodiment, the therapeutic agent is an anti-restenotic agent. In other embodiments, the therapeutic agent inhibits smooth muscle cell proliferation, contraction, migration or hyperactivity. Non-limiting examples of suitable therapeutic agent include heparin, heparin derivatives, urokinase, dextrophenylalanine proline arginine chloromethylketone (PPack), enoxaprin, angiopeptin, hirudin, acetylsalicylic acid, tacrolimus, everolimus, zotarolimus, rapamycin (sirolimus), pimecrolimus, amlodipine, doxazosin, glucocorticoids, betarnethasone, dexamethasone, prednisolone, corticosterone, budesonide, sulfasalazine, rosiglitazone, mycophenolic acid, mesalamine, paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, methotrexate, azathioprine, adriamycin, mutamycin, endostatin, angiostatin, thymidine kinase inhibitors, cladribine, lidocaine, bupivacaine, r6pivacaine, D-Phe-Pro-Arg chloromethyl ketone, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, aspirin, dipyridamole, protamine, hirudin, prostaglandin inhibitors, platelet inhibitors, trapidil, liprostin, tick antiplatelet peptides, 5-azacytidine, vascular endothelial growth factors, growth factor receptors, transcriptional activators, translational promoters, antiproliferative agents, growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin, cholesterol lowering agents, vasodilating agents, agents which interfere with endogenous vasoactive mechanisms, antioxidants, probucol, antibiotic agents, penicillin, cefoxitin, oxacillin, tobranycin, angiogenic substances, fibroblast growth factors, estrogen, estradiol (E2), estriol (E3), 17-beta estradiol, digoxin, beta blockers, captopril, enalopril, statins, steroids, vitamins, paclitaxel (as well as its derivatives, analogs or paclitaxel bound to proteins, e.g. AbraxaneTM) 2'-succinyl-taxol, 2'-succinyl-taxol triethanolamine, 2'-glutaryl-taxol, 2'-glutaryl-taxol triethanolamine salt, 2'-O-ester with N-(dimethylaminoethyl) glutamine, 2'-O-ester with N-(dimethylaminoethyl) glutamide hydrochloride salt, nitroglycerin, nitrous oxides, nitric oxides, antibiotics, aspirins, digitalis, estrogen, estradiol and glycosides. In one embodiment, the therapeutic agent is a smooth muscle cell inhibitor or antibiotic. In a preferred embodiment, the therapeutic agent is taxol (e.g., Taxol ), or its analogs or derivatives. In another preferred embodiment, the therapeutic agent is paclitaxel, or its analogs or derivatives. In yet another preferred embodiment, the therapeutic agent is an antibiotic such as erythromycin, amphotericin, rapamycin, adriamycin, etc.
[0072] The term "genetic materials" means DNA or RNA, including, without limitation, of DNA/RNA encoding a useful protein stated below, intended to be inserted into a human body including viral vectors and non-viral vectors.
[0073] The term "biological materials" include cells, yeasts, bacteria, proteins, peptides, cytokines and hormones. Examples for peptides and proteins include vascular endothelial growth factor (VEGF), transforming growth factor (TGF), fibroblast growth factor (FGF), epidermal growth factor (EGF), cartilage growth factor (CGF), nerve growth factor (NGF), keratinocyte growth factor (KGF), skeletal growth factor (SGF), osteoblast-derived growth factor (BDGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF), cytokine growth factors (CGF), platelet-derived growth factor (PDGF), hypoxia inducible factor-1 (HIF-1), stem cell derived factor (SDF), stem cell factor (SCF), endothelial cell growth supplement (ECGS), granulocyte macrophage colony stimulating factor (GM-CSF), growth differentiation factor (GDF), integrin modulating factor (IMF), calmodulin (CaM), thymidine kinase (TK), tumor necrosis factor (TNF), growth hormone (GH), bone morphogenic protein (BMP) (e.g., BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (PO-1), BMP-8, BMP-9, BMP-10, BMP-I 1, BMP-12, BMP-14, BMP-15, BMP-16, etc.), matrix metalloproteinase (MMP), tissue inhibitor of matrix metalloproteinase (TIMP), cytokines, interleukin (e.g., IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, IL-15, etc.), lymphokines, interferon, integrin, collagen (all types), elastin, fibrillins, fibronectin, vitronectin, laminin, glycosaminoglycans, proteoglycans, transferrin, cytotactin, cell binding domains (e.g., RGD), and tenascin. Currently preferred BMP's are BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7. These dimeric proteins can be provided as homodimers, heterodimers, or combinations thereof, alone or together with other molecules. Cells can be of human origin (autologous or allogeneic) or from an animal source (xenogeneic), genetically engineered, if desired, to deliver proteins of interest at the transplant site. The delivery media can be formulated as needed to maintain cell function and viability. Cells include progenitor cells (e.g., endothelial progenitor cells), stem cells (e.g., mesenchymal, hematopoietic, neuronal), stromal cells, parenchymal cells, undifferentiated cells, fibroblasts, macrophage, and satellite cells.
[0074] Other non-genetic therapeutic agents include:
= anti-thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone);
= anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, acetylsalicylic acid, tacrolimus, everolimus, amlodipine and doxazosin;
= anti-inflammatory agents such as glucocorticoids, betamethasone, dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, rosiglitazone, mycophenolic acid and mesalamine;
. anti-neoplastic/anti-proliferative/anti-miotic agents such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, methotrexate, azathioprine, adriamycin and mutamycin; endostatin, angiostatin and thymidine kinase inhibitors, cladribine, taxol and its analogs or derivatives;
= anesthetic agents such as lidocaine, bupivacaine, and ropivacaine;
= anti-coagulants such as D-Phe-Pro-Arg chloromethyl ketone, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, aspirin (aspirin is also classified as an analgesic, antipyretic and anti-inflammatory drug), dipyridamole, protamine, hirudin, prostaglandin inhibitors, platelet inhibitors, antiplatelet agents such as trapidil or liprostin and tick antiplatelet peptides;
= DNA demethylating drugs such as 5-azacytidine, which is also categorized as a RNA or DNA metabolite that inhibit cell growth and induce apoptosis in certain cancer cells;
. vascular cell growth promoters such as growth factors, vascular endothelial growth factors (VEGF, all types including VEGF-2), growth factor receptors, transcriptional activators, and translational promoters;
= vascular cell growth inhibitors such as anti-proliferative agents, growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin;
= cholesterol-lowering agents, vasodilating agents, and agents which interfere with endogenous vasoactive mechanisms;
= anti-oxidants, such as probucol;
a antibiotic agents, such as penicillin, cefoxitin, oxacillin, tobranycin, rapamycin (sirolimus);
= angiogenic substances, such as acidic and basic fibroblast growth factors, estrogen including estradiol (E2), estriol (E3) and 17-beta estradiol;
= drugs for heart failure, such as digoxin, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors including captopril and enalopril, statins and related compounds; and = macrolides such as sirolimus, everolimus or zotarolimus.
[0075] Preferred biological materials include anti-proliferative drugs such as steroids, vitamins, and restenosis-inhibiting agents. Preferred restenosis-inhibiting agents include microtubule stabilizing agents such as Taxol , paclitaxel (i.e., paclitaxel, paclitaxel analogs, or paclitaxel derivatives, paclitaxel conjugates and mixtures thereof).
For example, derivatives suitable for use in the present invention include 2'-succinyl-taxol, 2'-succinyl-taxol triethanolamine, 2'-glutaryl-taxol, 2'-glutaryl-taxol triethanolamine salt, 2'-O-ester with N-(dimethylaminoethyl) glutamine, paclitaxel 2-N-methypyridinium mesylate, and 2'-O-ester with N-(dimethylaminoethyl) glutamide hydrochloride salt. Paclitaxel conjugates suitable for use in the present invention include, paclitaxel conjugated with docosahexanoic acid (DHA), paclitaxel conjugated with a polyglutimate (PG) polymer and paclitaxel poliglumex.
[0076] Other suitable therapeutic agents include tacrolimus; halofuginone;
inhibitors of HSP90 heat shock proteins such as geldanarnycin; microtubule stabilizing agents such as epothilone D; phosphodiesterase inhibitors such as cliostazole; Barkct inhibitors;
phospholamban inhibitors; and Serca 2 gene/proteins.
[0077] Other preferred therapeutic agents include nitroglycerin, nitrous oxides, nitric oxides, aspirins, digitalis, estrogen derivatives such as estradiol and glycosides.
[0078] In one embodiment, the therapeutic agent is capable of altering the cellular metabolism or inhibiting a cell activity, such as protein synthesis, DNA
synthesis, spindle fiber formation, cellular proliferation, cell migration, microtubule formation, microffilarnent formation, extracellular matrix synthesis, extracellular matrix secretion, or increase in cell volume. In another embodiment, the therapeutic agent is capable of inhibiting cell proliferation and/or migration.
[0079] In certain embodiments, the therapeutic agents for use in the medical devices of the present invention can be synthesized by methods well known to one skilled in the art. Alternatively, the therapeutic agents can be purchased from chemical and pharmaceutical companies.
[0080] In some embodiments, the therapeutic agent comprises at least 1%, at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% or more by weight of the coating. When the coating includes a therapeutic agent without a polymer the therapeutic agent is preferably about 90% to about 100% by weight of the coating.
When the coating includes a therapeutic agent and a polymer the therapeutic agent is preferably about 1% to about 90% by weight of the coating. Additionally, a combination of therapeutic agents can be used in the coatings of the present invention.

C. Polvmers [0081] Polymers suitable for use, optionally, in the coatings preferably are ones that are biocompatible; however, non-biocompatible polymers can be used. Exarnples of such polymers include, but not limited to, polyurethanes, polyisobutylene and its copolymers, silicones, and polyesters. Other suitable polymers include polyolefins, polyisobutylene, ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers such as polyvinyl chloride, polyvinyl ethers such as polyvinyl methyl ether, polyvinylidene halides such as polyvinylidene fluoride and polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics such as polystyrene, polyvinyl esters such as polyvinyl acetate; copolymers of vinyl monomers, copolymers of vinyl monomers and olefins such as ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS resins, ethylene-vinyl acetate copolymers, polyamides such as Nylon 66 and polycaprolactone, alkyd resins, polycarbonates, polyoxyethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, collagens, chitins, polylactic acid, polyglycolic acid, and polylactic acid-polyethylene oxide copolymers.

[0082] When the polymer is being applied to a part of the medical device, such as a stent, which undergoes mechanical challenges, e.g. expansion and contraction, the polymers are preferably selected from elastomeric polymers such as silicones (e.g.
polysiloxanes and substituted polysiloxanes), polyurethanes, thermoplastic elastomers, ethylene vinyl acetate copolymers, polyolefin elastomers, and EPDM rubbers.
The polymer is selected to allow the coating to better adhere to the surface of the strut when the stent is subjected to forces or stress. Furkhermore, although the coating can be formed by using a single type of polymer, various combinations of polymers can be employed.
[0083] Examples of suitable hydrophobic polymers or monomers include, but not limited to, polyolefins, such as polyethylene, polypropylene, poly(l-butene), poly(2-butene), poly(1-pentene), poly(2-pentene), poly(3 -methyl- I -pentene), poly(4-methyl-l-pentene), poly(isoprene), poly(4-methyl-l-pentene), ethylene-propylene copolymers, ethylene-propylene-hexadiene copolymers, ethylene-vinyl acetate copolymers, blends of two or more polyolefins and random and block copolymers prepared from two or more different unsaturated monomers; styrene polymers, such as poly(styrene), poly(2-methylstyrene), styrene-acrylonitrile copolymers having less than about 20 mole-percent acrylonitrile, and styrene-2,2,3,3,-tetrafluoropropyl methacrylate copolymers;
halogenated hydrocarbon polymers, such as poly(chlorotrifluoroethylene), chlorotrifluoroethylene-tetrafluoroethylene copolymers, poly(hexafluoropropylene), poly(tetrafluoroethylene), tetrafluoroethylene, tetrafluoroethylene-ethylene copolymers, poly(trifluoroethylene), poly(vinyl fluoride), and poly(vinylidene fluoride);
vinyl polymers, such as poly(vinyl butyrate), poly(vinyl decanoate), poly(vinyl dodecanoate), poly(vinyl hexadecanoate), poly(vinyl hexanoate), poly(vinyl propionate), poly(vinyl octanoate), poly(heptafluoroisopropoxyethylene), poly(heptafluoroisopropoxy-propylene), and poly(methacrylonitrile); acrylic polymers, such as poly(n-butyl acetate), poly(ethyl acrylate), poly(1-chlorodifluoromethyl)tetrafluoroethyl acrylate, poly di(chlorofluoromethyl)fluoromethyl acrylate, poly(1,1-dihydroheptafluorobutyl acrylate), poly(1,1-dihydropentafluoroisopropyl acrylate), poly(1,1-dihydro-pentadecafluorooctyl acrylate), poly(heptafluoroisopropyl acrylate), poly 5-(heptafluoroisopropoxy)pentyl acrylate, poly 11-(heptafluoroisopropoxy)undecyl acrylate, poly 2-(heptafluoropropoxy)ethyl acrylate, and poly(nonafluoroisobutyl acrylate); methacrylic polymers, such as poly(benzyl methacrylate), poly(n-butyl methacrylate), poly(isobutyl methacrylate), poly(t-butyl methacrylate), poly(t-butylaminoethyl methacrylate), poly(dodecyl methacrylate), poly(ethyl methacrylate), poly(2-ethylhexyl methacrylate), poly(n-hexyl methacrylate), poly(phenyl methacrylate), poly(n-propyl methacrylate), poly(octadecyl methacrylate), poly(1,1-dihydropentadecafluorooctyl methacrylate), poly(heptafluoroisopropyl methacrylate), poly(heptadecafluorooctyl methacrylate), poly(1-hydrotetrafluoroethyl methacrylate), poly(1,1-dihydrotetrafluoropropyl methacrylate), poly(1-hydrohexa#luoroisopropyl methacrylate), and poly(t-nonafluorobutyl methacrylate); polyesters, such a poly(ethylene terephthalate) and poly(butylene terephthalate); condensation type polymers such as and polyurethanes and siloxane-urethane copolymers;
polyorganosiloxanes, i.e., polymeric materials characterized by repeating siloxane groups, represented by Ra SiO4_aa, where R is a monovalent substituted or unsubstituted hydrocarbon radical and the value of a is 1 or 2; and naturally occurring hydrophobic polymers such as rubber.
[0084] Examples of suitable hydrophilic polymers or monomers include, but not limited to; (meth)acrylic acid, or alkaline metal or ammonium salts thereof;
(meth)acrylamide; (meth)acrylonitrile; those polymers to which unsaturated dibasic, such as maleic acid and fumaric acid or half esters of these unsaturated dibasic acids, or alkaline metal or ammonium salts of these dibasic adds or half esters, is added; those polymers to which unsaturated sulfonic, such as 2-acrylamido-2-methylpropanesulfonic, 2-(meth)acryloylethanesulfonic acid, or alkaline metal or ammonium salts thereof, is added; and 2-hydroxyethyl (meth)acrylate and 2-hydroxypropyl (meth)acrylate.
[00851 Polyvinyl alcohol is also an example of hydrophilic polymer. Polyvinyl alcohol may contain a plurality of hydrophilic groups such as hydroxyl, amido, carboxyl, amino, anunonium or sulfonyl (-SO3). Hydrophilic polymers also include, but are not limited to, starch, polysaccharides and related cellulosic polymers;
polyalkylene glycols and oxides such as the polyethylene oxides; polymerized ethylenically unsaturated carboxylic acids such as acrylic, mathacrylic and maleic acids and partial esters derived from these acids and polyhydric alcohols such as the alkylene glycols;
homopolymers and copolymers derived from acrylamide; and homopolynmers and copolymers of vinylpyrrolidone.
[0086] Other suitable polymers include without limitation: polyurethanes, silicones (e.g., polysiloxanes and substituted polysiloxanes), and polyesters, styrene-isobutylene-copolymers. Other polymers which can be used include ones that can be dissolved and cured or polymerized on the medical device or polymers having relatively low melting points that can be blended with therapeutic agents. Additional suitable polymers include, but are not limited to, thermoplastic elastomers in general, polyolefins, polyisobutylene, ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers and copolymers such as polyvinyl chloride, polyvinyl ethers such as polyvinyl methyl ether, polyvinylidene halides such as polyvinylidene fluoride and polyvinylidene chloride, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics such as polystyrene, polyvinyl esters such as polyvinyl acetate, copolymers of vinyl monomers, copolymers of vinyl monomers and olefins such as ethylene-methyl methacrylate copolymers, acrylonitrile-styrene copolymers, ABS (acrylonitrile-butadiene-styrene) resins, ethylene-vinyl acetate copolymers, polyamides such as Nylon 66 and polycaprolactone, alkyd resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, polyether block amides, epoxy resins, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxyrnethyl cellulose, collagens, chitins, polylactic acid, polyglycolic acid, polylactic acid-polyethylene oxide copolymers, EPDM (ethylene-propylene-diene) rubbers, fluoropolymers, fluorosilicones, polyethylene glycol, polysaccharides, phospholipids, and combinations of the foregoing.
[0087] In certain embodiments block-copolymers are preferred for their ability to help create mesostructured and/or mesoporous coatings. In certain embodiments preferred polymers include, but are not limited to, a polyether, Nylon and polyether copolymers such as PEBAX, a polystyrene copolymer, a polyurethane, an ethylene vinyl acetate copolymer, a polyethylene glycol, a fluoropolymer, a polyaniline, a polythiophene, a polypyrrole, a maleated block copolymer, a polymethylmethacrylate, a polyethylenetheraphtalate or a combination thereof.
[0088] In some embodiments, when the first coating composition includes a polymer, the polymer comprises at least 5%, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% or more by weight of the coating. Preferably, the polymer is about 1% to about 80% by weight of the first coating composition.
More preferably, the polymer is about 60% to about 92% by weight of the first coating composition. Additionally, a combination of polymers can be used in the first coating composition of the present invention.

D. Methods of Making Coatings [0089] The present invention also relates to methods of making a medical device comprising a coating, wherein the coating comprises a first coating composition comprising a therapeutic agent and a second coating composition comprising a metallic material. Optionally the first coating composition can further comprise a polymer. In certain embodiments, the method comprises (a) providing a medical device having a surface, (b) disposing on at least a portion of the surface a first coating composition comprising a therapeutic agent; and (c) disposing on at least a portion of the first coating composition, a second coating composition comprising a metallic material and that is substantially free of any polymer.
[0090] In other embodiments, the method of the present invention comprises (a) providing a medical device having a surface, (b) disposing on at least a portion of the surface a first coating composition comprising a therapeutic agent and a polymer; and (c) disposing on at least a portion of the first coating composition, a second coating composition comprising a metallic material and that is substantially free of any polymer.
[0091] In such embodiments the first coating composition may be disposed on the surface of a medical device by any suitable method, such as, but not limited to, spraying for example by using a conventional nozzle or ultrasonic nozzle; dipping;
rolling;
electrostatic deposition; spin coating; plasma deposition; condensation;
electrochemical deposition; electrostatic deposition; evaporation; plasma-vapor deposition;
cathodic-arc deposition; sputtering; ion implantation; or use of a fluidized bed or a batch process such as, air suspension, pan coating or ultrasonic mist spraying.
[0092] The first coating composition can be made by dissolving or dispersing the therapeutic agent solvent to form a solution or suspension and the solution or suspension can be disposed on the surface of a medical device and the solvent can be removed.
Alternatively, if the first coating composition includes a polymer, a therapeutic agent and a polymer can be dissolved or dispersed in a solvent to form a solution or suspension and the solution or suspension can be disposed on the surface of a medical device and the solvent can be removed. Also, a therapeutic agent and a polymer may be mixed together until the therapeutic agent is dissolved or dispersed in the polymer and the mixture can then be disposed of the surface of a medical device.
[0093] The second coating composition comprising a metallic material can be disposed on the first coating composition by any suitable methods , such as, but not limited to, spraying for example by using a conventional nozzle or ultrasonic nozzle;

dipping; rolling; electrostatic deposition; spin coating; plasma deposition;
condensation;
electrochemical deposition; electrostatic deposition; evaporation; plasma-vapor deposition; cathodic-arc deposition; sputtering; ion implantation; or use of a fluidized bed or a batch process such as, air suspension, pan coating, ultrasonic mist spraying or thermal spraying.
[0094] Prior to deposition, the metallic material in the second coating composition can be placed into a solution or suspension to facilitate deposition.
Solutions can be formed using suitable solvents and metallic compounds. Suspensions can be formed by mixing metallic powders with solvents or polymer binders and solvents.
[0095] In certain embodiments, the first coating composition can be disposed on at least a portion of the surface of a medical device and then a second coating composition can be disposed on at least a portion of the first coating composition. In some embodiments, the second coating composition comprising a metallic material can be disposed on the first coating composition, as well as, at least a portion of the surface of the first coating composition. Alternatively, the second coating composition comprising a metallic material can be disposed on at least a portion of the surface of the medical device first and then the first coating composition can be disposed on another portion of the surface of the medical device.
[0096] Furthermore, pores can be formed or introduced in the second coating composition comprising a metallic material. Such pores can be introduced by any means known in the art. The pores in some instances can be created by micro-roughing techniques involving the use of reactive plasmas or ion bombardment electrolyte etching. The pores can also be created by other methods such as sand blasting, laser etching or chemical etching. In some instances, the pores can be formed by depositing the second coating composition comprising a metallic material in a particular manner so that pores form in the metallic material. For example, the second coating composition can be made porous by a deposition process such as sputtering and adjusting the deposition condition. Deposition conditions that can be adjusted or varied include, but are not limited to, chamber pressure, substrate temperature, substrate bias, substrate orientation, sputter rate, or a combination thereof.
100971 In an alternative method, the pores may be formed using thermal plasma spraying of a spray composition under certain process parameters that promote the formation of pores.
[0098] In addition, pores can be formed by a co-deposition technique. In such a technique the second coating composition comprising a metallic material is combined with a secondary phase material to form a composition. The secondary phase material can be non-metal secondary materials, such as a polymer, that are capable of being leached off, such as polystyrene. The secondary phase material can be in the form of particles such as hollow spheres or chopped tubes of various sizes. The size and shape of the pores formed will be determined by the size and shape of the secondary phase material. For example, if the secondary phase material is in the shape of a sphere, the pores formed will be in the shape of spheres.
[0099] In some embodiments, the secondary phase material can be a second metallic material. The two metallic materials can form an alloy such as a gold/silver alloy, where gold is the metal used as the metallic material in the second coating composition and silver is the secondary phase material. Also, the two metals can be in the form of a mixture or a composite. Thus, if two metals are used in the composition, the metals should have different chemical or physical properties to facilitate removal of the metal that is used as the secondary phase material. For example, the metal that will be removed should be more electrochemically active, e.g., less corrosion-resistant than the metal used to form the porous coating. In some embodiments, the metal that will be removed should have a lower melting point than the metal used to form the second coating composition. In yet another embodiment, the metal that will be removed should have a higher vapor pressure than the metal used to form the coating. Also, in another embodiment, the metal that is removed is more susceptible to being dissolved in a chosen solvent than the metal used to form the coating.
[0100] A composition containing the second coating composition comprising a metallic material and a secondary phase material is applied to the surface of the medical device. Suitable application methods include but are not limited to, dipping, spraying, painting, electroplating, evaporation, plasma vapor deposition, cathodic arc deposition, sputtering, ion implantation, electrostatically, electroplating, electrochemically, or a combination thereof.
[0101] Afterwards, the secondary phase material is removed from the composition to form a porous second coating composition. For example, the secondary phase material may be removed from the composition by a dealloying process such as selective dissolution of the secondary phase material. In this method, the composition is exposed to an acid which removes the secondary phase material. Thus, the metallic material used to form the second coating composition is preferably one that will not dissolve when exposed to the acid, while the secondary phase material is one that will dissolve in the acid. Any suitable acid can be used to remove the secondary phase material.
One of ordinary skill in the art would recognize the appropriate concentration and reaction conditions to use. For example, if the secondary phase material is silver, nitric acid may be used at a concentration of up to 35% and a temperature up to 120 F. Also, a nitric acid and sulfuric acid mixture (95%/5%) immersion process at 80 F may be used.
The reaction conditions may be varied to vary the geometry, distribution, and depth of the coating.
[0102] Alternatively, the second metal can be removed anodically. For example, when silver is used as the secondary phase material, the silver may be removed from the composition applied to the surface anodically using a dilute nitric acid bath comprising up to 15% nitric acid, wherein the anode is the medical device, and the cathode comprises platinum. Voltages up to I OV DC can be applied across the electrodes. The bath chemistry, temperature, applied voltage, and process time may be varied to vary the geometry, distribution, and depth of the coating.
[0103] Furthermore, if the secondary phase material has a lower melting point than the metallic material used in the second coating composition, the device coated with the composition containing the second coating composition comprising a metallic material and the secondary phase material can be heated to a temperature such that the secondary phase material becomes a liquid and is removable from the second coating composition.
Examples of suitable metals for the second coating composition include one of the higher melting point first metals: platinum, gold, stainless steel, titanium, tantalum, and iridium, in combination with a lower melting point secondary phase material such as:
aluminum, barium, and bismuth.
[0104] In another embodiment, the secondary phase material has a higher vapor pressure than the second coating composition comprising a metallic material.
When the composition applied to the surface of the medical device is heated under vacuum the secondary phase material becomes vaporized and is removed from the second coating composition.
[0105] The description contained herein is for purposes of illustration and not for purposes of limitation. Changes and modifications may be made to the embodiments of the description and still be within the scope of the invention. Furthermore, obvious changes, modifications or variations will occur to those skilled in the art.
Also, all references cited above are incorporated herein, in their entirety, for all purposes related to this disclosure.

Claims (30)

WHAT IS CLAIMED:
1. An implantable intravascular stent comprising:
(a) a stent sidewall structure having a surface; and (b) a coating comprising:
(i) a first coating composition comprising a therapeutic agent disposed upon at least a portion of the surface of the stent sidewall structure, wherein the first coating composition when disposed on the portion of the surface of the stent sidewall structure has an outer surface; and (ii) a second coating composition comprising a metallic material disposed on at least a portion of the first coating composition, wherein the second coating composition is substantially free of any polymer when applied to the portion of the first coating composition; and wherein after the second coating composition is applied to the portion of the first coating composition the second coating composition comprises an outer surface and a plurality of pores, in which the pores extend from the outer surface of the first coating composition to the outer surface of the second coating composition.
2. The stent of claim 1, wherein the second coating composition is disposed on less than the entire outer surface of the first coating composition.
3. The stent of claim 1, wherein the surface of the stent sidewall structure is an abluminal surface.
4. The stent of claim 3, wherein the stent sidewall structure further comprises an adluminal surface and wherein the first coating composition is disposed on at least a portion of the adluminal surface.
5. The stent of claim 4, wherein the adluminal surface is free of the second coating composition.
6. The stent of claim 4, wherein the second coating composition is disposed on at least a portion of the first coating composition disposed on the adluminal surface.
7. The stent of claim 1, wherein the stent sidewall structure comprises a plurality of struts each having an abluminal surface and an adluminal surface and wherein the surface of the stent sidewall structure is the abluminal surface of at least one of the struts.
8. The stent of claim 7, wherein the first coating composition is disposed on at least a portion of the adluminal surface of at least one of the struts.
9. The stent of claim 8, wherein the adluminal surface of the strut is free of the second coating composition.
10. The stent of claim 8, wherein the second coating composition is disposed on at least a portion of the first coating composition disposed on the adluminal surface of the strut.
11. The stent of claim 1, wherein the stent sidewall structure comprises a plurality of openings therein.
12. The stent of claim 11, wherein the first and second coating compositions conform to the stent sidewall structure to preserve the openings in the stent sidewall structure.
13. The stent of claim 1, wherein the therapeutic agent comprises an agent that inhibits smooth muscle cell proliferation.
14. The stent of claim 1, wherein the therapeutic agent comprises an anti-thrombogenic agent, anti-angiogenesis agent, anti-proliferative agent, antibiotic, anti-restenosis agent, growth factor, immunosuppressant or radiochemical.
15. The stent of claim 1, wherein the therapeutic agent comprises an anti-restenosis agent.
16. The stent of claim 1, wherein the therapeutic agent comprises paclitaxel.
17. The stent of claim 1, wherein the therapeutic agent comprises sirolimus, tacrolimus, pimecrolimus, everolimus or zotarolimus.
18. The stent of claim 1, wherein the metallic material is selected from the group consisting of stainless steel, nickel, titanium, chromium and alloys thereof.
19. The stent of claim 1, wherein the first coating composition further comprises at least one polymer.
20. The stent of claim 17, wherein the polymer is selected from the group consisting of styrene-isobutylene copolymer, polylactic acid, poly(methylmethacrylate-butylacrylate-methylmethacrylate).
21. The stent of claim 1, wherein the first coating composition forms a first layer having a thickness of about 1 to about 30 microns.
22. The stent of claim 1, wherein the second coating composition forms a second layer having a thickness of about 0.1 to about 50 microns.
23. An implantable intravascular stent comprising:
(a) a stent sidewall structure comprising a plurality of struts each having an abluminal surface and an adluminal surface;
(b) a first coating disposed on the abluminal surface of at least one strut comprising:
(i) a first coating composition comprising an anti-restenosis agent disposed upon at least a portion of the abluminal surface of the strut, wherein the first coating composition when disposed on the portion of the surface of the abluminal surface of the strut has an outer surface; and (ii) a second coating composition comprising a metallic material disposed on at least a portion of the first coating composition, wherein the second coating composition is substantially free of any polymer; and wherein after the second coating composition is applied to the portion of the first coating composition the second coating composition comprises an outer surface and a plurality of pores, in which the pores extend from the outer surface of the first coating composition to the outer surface of the second coating composition; and (c) a second coating disposed on at least a portion of the adluminal surface of the at least one strut comprising the first coating composition.
24. An implantable intravascular stent comprising:
(a) a stent sidewall structure comprising (1) a plurality of struts each having an abluminal surface and an adluminal surface, and (2) openings in the stent sidewall structure;
(b) a first coating disposed on the abluminal surface of at least one strut comprising:
(i) a first coating composition comprising an anti-restenosis agent disposed upon at least a portion of the abluminal surface of the strut, wherein the first coating composition when disposed on the portion of the surface of the abluminal surface of the strut has an outer surface; and (ii) a second coating composition comprising a metallic material disposed on at least a portion of the first coating composition, wherein the second coating composition is substantially free of any polymer; and wherein after the second coating composition is applied to the portion of the first coating composition the second coating composition comprises an outer surface and a plurality of pores, in which the pores extend from the outer surface of the first coating composition to the outer surface of the second coating composition; and (c) a second coating disposed on at least a portion of the adluminal surface of the at least one strut comprising the first coating composition, wherein the adluminal surface of the at least one strut is free of the second coating composition; and wherein the first and second coatings conform to the stent sidewall structure to preserve the openings therein.
25. An implantable intravascular stent comprising:
(a) a stent sidewall structure having a surface; and (b) a coating comprising:
(i) a first coating composition comprising a therapeutic agent disposed upon at least a portion of the surface of the stent sidewall structure wherein the first coating composition has a first thickness; and (ii) a second coating composition comprising a metallic material disposed upon at least a portion of the surface of the stent sidewall structure, wherein the second coating composition has a second thickness and is substantially free of any polymer; and wherein the second thickness of the second coating composition is the same as or greater than the first thickness of the first coating composition.
26. The stent of claim 25, wherein the second thickness of the second coating composition is greater than the first thickness of the first coating composition.
27. The stent of claim 25, wherein the first thickness of the first coating composition is equal to the second thickness of the second coating composition.
28. The stent of claim 25, wherein the first coating further comprises a polymer.
29. The stent of claim 25, wherein the second coating composition is disposed adjacent to the first coating composition on the surface of the stent sidewall structure.
30. The stent of claim 25, wherein the stent sidewall structure comprises a plurality of struts and openings and the surface of the stent sidewall structure is the abluminal surface of the stent.
CA002657109A 2006-06-28 2007-06-25 Coatings for medical devices comprising a therapeutic agent and a metallic material Abandoned CA2657109A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/478,095 2006-06-28
US11/478,095 US8815275B2 (en) 2006-06-28 2006-06-28 Coatings for medical devices comprising a therapeutic agent and a metallic material
PCT/US2007/014851 WO2008002586A2 (en) 2006-06-28 2007-06-25 Coatings for medical devices comprising a therapeutic agent and a metallic material

Publications (1)

Publication Number Publication Date
CA2657109A1 true CA2657109A1 (en) 2008-01-03

Family

ID=38691758

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002657109A Abandoned CA2657109A1 (en) 2006-06-28 2007-06-25 Coatings for medical devices comprising a therapeutic agent and a metallic material

Country Status (5)

Country Link
US (2) US8815275B2 (en)
EP (1) EP2051750B1 (en)
JP (1) JP5185263B2 (en)
CA (1) CA2657109A1 (en)
WO (1) WO2008002586A2 (en)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713297B2 (en) * 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US8458879B2 (en) * 2001-07-03 2013-06-11 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Method of fabricating an implantable medical device
US7727221B2 (en) 2001-06-27 2010-06-01 Cardiac Pacemakers Inc. Method and device for electrochemical formation of therapeutic species in vivo
US7758892B1 (en) * 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices having multiple layers
US20060127443A1 (en) * 2004-12-09 2006-06-15 Helmus Michael N Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US20070038176A1 (en) * 2005-07-05 2007-02-15 Jan Weber Medical devices with machined layers for controlled communications with underlying regions
US8840660B2 (en) * 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) * 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20070224244A1 (en) * 2006-03-22 2007-09-27 Jan Weber Corrosion resistant coatings for biodegradable metallic implants
US20070224235A1 (en) * 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) * 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8048150B2 (en) * 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US20070264303A1 (en) * 2006-05-12 2007-11-15 Liliana Atanasoska Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2008002778A2 (en) * 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
CA2659761A1 (en) 2006-08-02 2008-02-07 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having drug-eluting film
ES2368125T3 (en) 2006-09-15 2011-11-14 Boston Scientific Scimed, Inc. BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS.
EP2959925B1 (en) * 2006-09-15 2018-08-29 Boston Scientific Limited Medical devices and methods of making the same
US8808726B2 (en) * 2006-09-15 2014-08-19 Boston Scientific Scimed. Inc. Bioerodible endoprostheses and methods of making the same
CA2663271A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
WO2008036548A2 (en) * 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
CA2663717A1 (en) * 2006-09-18 2008-03-27 Boston Scientific Limited Controlling biodegradation of a medical instrument
EP2084310A1 (en) * 2006-10-05 2009-08-05 Boston Scientific Limited Polymer-free coatings for medical devices formed by plasma electrolytic deposition
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
EP2277563B1 (en) * 2006-12-28 2014-06-25 Boston Scientific Limited Bioerodible endoprostheses and method of making the same
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) * 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8002823B2 (en) * 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
EP2187988B1 (en) 2007-07-19 2013-08-21 Boston Scientific Limited Endoprosthesis having a non-fouling surface
DE102007034364A1 (en) * 2007-07-24 2009-01-29 Biotronik Vi Patent Ag Degradable metal stent with active ingredient-containing coating
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) * 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US8221822B2 (en) * 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
WO2009020520A1 (en) * 2007-08-03 2009-02-12 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US20090118809A1 (en) * 2007-11-02 2009-05-07 Torsten Scheuermann Endoprosthesis with porous reservoir and non-polymer diffusion layer
US8029554B2 (en) * 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090143855A1 (en) * 2007-11-29 2009-06-04 Boston Scientific Scimed, Inc. Medical Device Including Drug-Loaded Fibers
US20100008970A1 (en) * 2007-12-14 2010-01-14 Boston Scientific Scimed, Inc. Drug-Eluting Endoprosthesis
WO2009131911A2 (en) 2008-04-22 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) * 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
EP2303350A2 (en) 2008-06-18 2011-04-06 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7985252B2 (en) * 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) * 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8231980B2 (en) * 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8267992B2 (en) * 2009-03-02 2012-09-18 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) * 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) * 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US20100274352A1 (en) * 2009-04-24 2010-10-28 Boston Scientific Scrimed, Inc. Endoprosthesis with Selective Drug Coatings
RU2605793C2 (en) * 2009-05-29 2016-12-27 Энвижн Сайентифик Прайвит Лимитед RESUMPTION OF BLOOD FLOW IN HUMAN BLOCKED ARTERIES BY TRANSFERRING NANO INCAPSULATED DRUG BY MEANS OF MEDICAL DEVICES DESIGNED THEREFOR, AND RELEASE OF NANO INCAPSULATED DRUG WITHIN HUMAN ARTERY AT PHYSIOLOGIC pH LEVEL
US9283305B2 (en) * 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
US20110022158A1 (en) * 2009-07-22 2011-01-27 Boston Scientific Scimed, Inc. Bioerodible Medical Implants
US8828474B2 (en) 2009-09-20 2014-09-09 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8381774B2 (en) * 2009-09-20 2013-02-26 Medtronic Vascular, Inc. Methods for loading a drug eluting medical device
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) * 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
AU2011218197B2 (en) 2010-02-16 2015-05-21 Boston Scientific Scimed, Inc. Bioabsorbable mesh for surgical implants
US8668732B2 (en) * 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
CN102711676A (en) * 2010-03-30 2012-10-03 泰尔茂株式会社 Stent
JP5902165B2 (en) * 2010-08-02 2016-04-13 コーディス・コーポレイションCordis Corporation Flexible spiral stent with different spiral regions
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8632846B2 (en) 2010-09-17 2014-01-21 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
AU2012220537A1 (en) * 2011-02-23 2013-08-29 Ams Research Corporation Pelvic implant and therapeutic agent system and method
IN2014CN03812A (en) * 2011-10-27 2015-10-16 Occlutech Holding Ag
US9750928B2 (en) 2013-02-13 2017-09-05 Becton, Dickinson And Company Blood control IV catheter with stationary septum activator
US9486340B2 (en) 2013-03-14 2016-11-08 Medtronic Vascular, Inc. Method for manufacturing a stent and stent manufactured thereby
US10376686B2 (en) 2014-04-23 2019-08-13 Becton, Dickinson And Company Antimicrobial caps for medical connectors
US9675793B2 (en) * 2014-04-23 2017-06-13 Becton, Dickinson And Company Catheter tubing with extraluminal antimicrobial coating
US10828400B2 (en) 2014-06-10 2020-11-10 The Research Foundation For The State University Of New York Low temperature, nanostructured ceramic coatings
US10232088B2 (en) 2014-07-08 2019-03-19 Becton, Dickinson And Company Antimicrobial coating forming kink resistant feature on a vascular access device
US10661261B2 (en) 2015-03-13 2020-05-26 The Research Foundation For The State University Of New York Metal oxide nanofibrous materials for photodegradation of environmental toxins
GB201508931D0 (en) * 2015-05-26 2015-07-01 Univ Glasgow The And Georgia Tech Res Corp Materials and methods for tissue regeneration
US10493244B2 (en) 2015-10-28 2019-12-03 Becton, Dickinson And Company Extension tubing strain relief
WO2018125012A1 (en) * 2016-12-28 2018-07-05 Istanbul Teknik Universitesi Electrical conductive surgical suture production method
WO2018187407A1 (en) * 2017-04-04 2018-10-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Mg alloy mesh reinforced polymer/ecm hybrid scaffolds for critical-sized bone defect regeneration
US11154059B2 (en) 2017-09-22 2021-10-26 David G. Whitten Substituted thiophene oligomers and polymers
GB2575045B8 (en) * 2018-06-25 2023-05-31 Rawwater Engineering Ltd Sealing device

Family Cites Families (940)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT232704B (en) 1959-03-31 1964-04-10 Plastic Textile Access Ltd Device for extrusion
NL135500C (en) 1964-03-04
SU393044A1 (en) 1968-09-03 1973-08-10 METHOD OF REINFORCEMENT OF METAL PRODUCTS BY GRAIN SOLID
US3751283A (en) 1971-03-08 1973-08-07 Remington Arms Co Inc Armored metal tools and production thereof
US3758396A (en) 1971-08-31 1973-09-11 Research Corp Ition preparation of immobilized enzymemembrane complexes by electrocodepos
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3910819A (en) 1974-02-19 1975-10-07 California Inst Of Techn Treatment of surfaces to stimulate biological cell adhesion and growth
US3970445A (en) 1974-05-02 1976-07-20 Caterpillar Tractor Co. Wear-resistant alloy, and method of making same
GB1527592A (en) 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3952334A (en) 1974-11-29 1976-04-27 General Atomic Company Biocompatible carbon prosthetic devices
US4101984A (en) 1975-05-09 1978-07-25 Macgregor David C Cardiovascular prosthetic devices and implants with porous systems
DE2620907C3 (en) 1976-05-12 1984-09-20 Battelle-Institut E.V., 6000 Frankfurt Anchoring for highly stressed endoprostheses
US4143661A (en) 1977-12-12 1979-03-13 Andros Incorporated Power supply for body implant and method for operation
SE416175B (en) 1979-03-07 1980-12-08 Per Ingvar Branemark FOR IMPLANTATION IN BODY TISSUE Separate Bone Tissue, Dedicated Material
US4237559A (en) 1979-05-11 1980-12-09 General Electric Company Bone implant embodying a composite high and low density fired ceramic construction
US4334327A (en) 1979-12-21 1982-06-15 University Of Utah Ureteral prosthesis
US4321311A (en) 1980-01-07 1982-03-23 United Technologies Corporation Columnar grain ceramic thermal barrier coatings
US4309996A (en) 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4308868A (en) 1980-05-27 1982-01-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Implantable electrical device
CH649578A5 (en) 1981-03-27 1985-05-31 Ulvac Corp HIGH-SPEED CATHODE SPRAYING DEVICE.
US4475972A (en) 1981-10-01 1984-10-09 Ontario Research Foundation Implantable material
US5968640A (en) 1985-04-23 1999-10-19 The Boeing Company Conductive, thermally stable oligomers
US4407695A (en) 1981-12-31 1983-10-04 Exxon Research And Engineering Co. Natural lithographic fabrication of microstructures over large areas
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4587121A (en) 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US4565744A (en) 1983-11-30 1986-01-21 Rockwell International Corporation Wettable coating for reinforcement particles of metal matrix composite
US4657544A (en) 1984-04-18 1987-04-14 Cordis Corporation Cardiovascular graft and method of forming same
US4585652A (en) 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
DE3516411A1 (en) 1985-05-07 1986-11-13 Plasmainvent AG, Zug COATING OF AN IMPLANT BODY
US4665896A (en) 1985-07-22 1987-05-19 Novacor Medical Corporation Power supply for body implant and method of use
US4705502A (en) 1985-11-06 1987-11-10 The Kendall Company Suprapubic catheter with dual balloons
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4738740A (en) 1985-11-21 1988-04-19 Corvita Corporation Method of forming implantable vascular grafts
US4743252A (en) 1986-01-13 1988-05-10 Corvita Corporation Composite grafts
DE3608158A1 (en) 1986-03-12 1987-09-17 Braun Melsungen Ag VESSELED PROSTHESIS IMPREGNATED WITH CROSSLINED GELATINE AND METHOD FOR THE PRODUCTION THEREOF
GB2189738B (en) 1986-03-24 1989-11-15 Ethicon Inc Apparatus for producing fibrous structures electrostatically
SE453258B (en) 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US5527337A (en) 1987-06-25 1996-06-18 Duke University Bioabsorbable stent and method of making the same
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
DE3821544C2 (en) 1988-06-25 1994-04-28 H Prof Dr Med Just Dilatation catheter
US5091205A (en) 1989-01-17 1992-02-25 Union Carbide Chemicals & Plastics Technology Corporation Hydrophilic lubricious coatings
US5163958A (en) 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
JPH02279575A (en) 1989-04-18 1990-11-15 Nkk Corp Production of sintered ceramic body having dense ceramic film
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5073365A (en) 1989-06-01 1991-12-17 Advanced Polymer Systems Clinical and personal care articles enhanced by lubricants and adjuvants
US5061914A (en) 1989-06-27 1991-10-29 Tini Alloy Company Shape-memory alloy micro-actuator
DE69027061T2 (en) 1989-06-30 1997-01-02 Tdk Corp Substitute material for living hard tissue, its manufacture and manufacture of a shaped body
US5649951A (en) 1989-07-25 1997-07-22 Smith & Nephew Richards, Inc. Zirconium oxide and zirconium nitride coated stents
DK0420488T3 (en) 1989-09-25 1993-08-30 Schneider Usa Inc Multilayer extrusion as a method for preparing angioplasty balloons
US5843089A (en) 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5439446A (en) 1994-06-30 1995-08-08 Boston Scientific Corporation Stent and therapeutic delivery system
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5674192A (en) 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5477864A (en) 1989-12-21 1995-12-26 Smith & Nephew Richards, Inc. Cardiovascular guidewire of enhanced biocompatibility
US5171607A (en) 1990-01-29 1992-12-15 Bausch & Lomb Incorporated Method of depositing diamond-like carbon film onto a substrate having a low melting temperature
US5378146A (en) 1990-02-07 1995-01-03 Ormco Corporation Polyurethane biomedical devices & method of making same
US5545208A (en) 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5236413B1 (en) 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
WO1991017724A1 (en) 1990-05-17 1991-11-28 Harbor Medical Devices, Inc. Medical device polymer
EP0484533B1 (en) 1990-05-19 1995-01-25 Anatoly Nikiforovich Papyrin Method and device for coating
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5120322A (en) 1990-06-13 1992-06-09 Lathrotec, Inc. Method and apparatus for treatment of fibrotic lesions
US5102403A (en) 1990-06-18 1992-04-07 Eckhard Alt Therapeutic medical instrument for insertion into body
US4976692A (en) 1990-09-13 1990-12-11 Travenol Laboratories (Israel) Ltd. Catheter particularly useful for inducing labor and/or for the application of a pharmaceutical substance to the cervix of the uterus
US5258020A (en) 1990-09-14 1993-11-02 Michael Froix Method of using expandable polymeric stent with memory
US5160790A (en) 1990-11-01 1992-11-03 C. R. Bard, Inc. Lubricious hydrogel coatings
US6524274B1 (en) 1990-12-28 2003-02-25 Scimed Life Systems, Inc. Triggered release hydrogel drug delivery system
US5205921A (en) 1991-02-04 1993-04-27 Queen's University At Kingston Method for depositing bioactive coatings on conductive substrates
DE4104359A1 (en) 1991-02-13 1992-08-20 Implex Gmbh CHARGING SYSTEM FOR IMPLANTABLE HOERHILFEN AND TINNITUS MASKERS
US5195969A (en) 1991-04-26 1993-03-23 Boston Scientific Corporation Co-extruded medical balloons and catheter using such balloons
US5326354A (en) 1991-05-09 1994-07-05 Howmedica Inc. Method for forming attachment surfaces on implants
US5147370A (en) 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5258098A (en) 1991-06-17 1993-11-02 Cycam, Inc. Method of production of a surface adapted to promote adhesion
US5242706A (en) 1991-07-31 1993-09-07 The United States Of America As Represented By The Secretary Of The Navy Laser-deposited biocompatible films and methods and apparatuses for producing same
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5219611A (en) 1991-09-30 1993-06-15 Cornell Research Foundation, Inc. Preparing densified low porosity titania sol gel forms
WO1993006792A1 (en) 1991-10-04 1993-04-15 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5500013A (en) 1991-10-04 1996-03-19 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5464450A (en) 1991-10-04 1995-11-07 Scimed Lifesystems Inc. Biodegradable drug delivery vascular stent
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
WO1993007924A1 (en) 1991-10-18 1993-04-29 Spire Corporation Bactericidal coatings for implants
US6001289A (en) 1991-12-04 1999-12-14 Materials Innovation, Inc. Acid assisted cold welding and intermetallic formation
US5314453A (en) 1991-12-06 1994-05-24 Spinal Cord Society Position sensitive power transfer antenna
US5348553A (en) 1991-12-18 1994-09-20 Whitney Douglass G Method for promoting blood vessel healing
US5193540A (en) 1991-12-18 1993-03-16 Alfred E. Mann Foundation For Scientific Research Structure and method of manufacture of an implantable microstimulator
US5591224A (en) 1992-03-19 1997-01-07 Medtronic, Inc. Bioelastomeric stent
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US6071567A (en) 1992-03-25 2000-06-06 Reeves Brothers, Inc. Formation of compressible ply containing high melting point thermoplastic microspheres and printing blankets comprising same
DE69332950T2 (en) 1992-03-31 2004-05-13 Boston Scientific Corp., Natick BLOOD VESSEL FILTER
US5807407A (en) 1992-05-04 1998-09-15 Biomet, Inc. Medical implant device and method for making same
IL106013A (en) 1992-07-13 1994-12-29 Litton Systems Inc Flip-up mount for night vision system
CA2074318A1 (en) 1992-07-22 1994-01-23 Morteza Shirkhanzadeh Prosthetic implant with self-generated current for early fixation in skeletal bone
US5614549A (en) 1992-08-21 1997-03-25 Enzon, Inc. High molecular weight polymer-based prodrugs
US5578075B1 (en) 1992-11-04 2000-02-08 Daynke Res Inc Minimally invasive bioactivated endoprosthesis for vessel repair
US5449382A (en) 1992-11-04 1995-09-12 Dayton; Michael P. Minimally invasive bioactivated endoprosthesis for vessel repair
US5322520A (en) 1992-11-12 1994-06-21 Implemed, Inc. Iontophoretic structure for medical devices
ES2166370T3 (en) 1993-01-19 2002-04-16 Schneider Usa Inc IMPLANTABLE FILAMENT IN COMPOSITE MATERIAL.
US5607463A (en) 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
US5380298A (en) 1993-04-07 1995-01-10 The United States Of America As Represented By The Secretary Of The Navy Medical device with infection preventing feature
US20020055710A1 (en) 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
US5824048A (en) 1993-04-26 1998-10-20 Medtronic, Inc. Method for delivering a therapeutic substance to a body lumen
US5464650A (en) 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5368881A (en) 1993-06-10 1994-11-29 Depuy, Inc. Prosthesis with highly convoluted surface
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
US5994341A (en) 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US6776094B1 (en) 1993-10-04 2004-08-17 President & Fellows Of Harvard College Kit For Microcontact Printing
US5776748A (en) 1993-10-04 1998-07-07 President And Fellows Of Harvard College Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor
US5397307A (en) 1993-12-07 1995-03-14 Schneider (Usa) Inc. Drug delivery PTCA catheter and method for drug delivery
US5788687A (en) 1994-02-01 1998-08-04 Caphco, Inc Compositions and devices for controlled release of active ingredients
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
JPH07257079A (en) 1994-03-25 1995-10-09 Dainippon Printing Co Ltd Optical card
US5693085A (en) 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US5788979A (en) 1994-07-22 1998-08-04 Inflow Dynamics Inc. Biodegradable coating with inhibitory properties for application to biocompatible materials
US6514289B1 (en) 2000-01-30 2003-02-04 Diamicron, Inc. Diamond articulation surface for use in a prosthetic joint
US6497727B1 (en) 2000-01-30 2002-12-24 Diamicron, Inc. Component for use in prosthetic hip, the component having a polycrystalline diamond articulation surface and a plurality of substrate layers
US5504385A (en) 1994-08-31 1996-04-02 At&T Corp. Spaced-gate emission device and method for making same
US5891108A (en) 1994-09-12 1999-04-06 Cordis Corporation Drug delivery stent
US5649977A (en) 1994-09-22 1997-07-22 Advanced Cardiovascular Systems, Inc. Metal reinforced polymer stent
EP0705911B1 (en) 1994-10-04 2001-12-05 General Electric Company Thermal barrier coating
BE1008955A3 (en) 1994-11-14 1996-10-01 Univ Catholique Louvain Process for obtaining and products obtained biomaterials.
CA2301351C (en) 1994-11-28 2002-01-22 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US5755722A (en) 1994-12-22 1998-05-26 Boston Scientific Corporation Stent placement device with medication dispenser and method
US6017577A (en) 1995-02-01 2000-01-25 Schneider (Usa) Inc. Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices
DE19506188C2 (en) 1995-02-22 2003-03-06 Miladin Lazarov Implant and its use
US6231600B1 (en) 1995-02-22 2001-05-15 Scimed Life Systems, Inc. Stents with hybrid coating for medical devices
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US6306144B1 (en) 1996-11-01 2001-10-23 Scimed Life Systems, Inc. Selective coating of a balloon catheter with lubricious material for stent deployment
US5605696A (en) 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US6120536A (en) 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
US5837313A (en) 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
AU4952096A (en) 1995-04-19 1996-11-07 Schneider (Usa) Inc. Drug release coated stent
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US5795626A (en) 1995-04-28 1998-08-18 Innovative Technology Inc. Coating or ablation applicator with a debris recovery attachment
DE69634013T2 (en) 1995-05-26 2005-12-15 SurModics, Inc., Eden Prairie PROCESS AND IMPLANTABLE OBJECT FOR PROMOTING ENDOTHELIALIZATION
US5674242A (en) 1995-06-06 1997-10-07 Quanam Medical Corporation Endoprosthetic device with therapeutic compound
US7550005B2 (en) 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
ATE224394T1 (en) 1995-06-16 2002-10-15 Kyowa Hakko Kogyo Kk DERIVATIVES OF DC 107
US6209621B1 (en) 1995-07-07 2001-04-03 Depuy Orthopaedics, Inc. Implantable prostheses with metallic porous bead preforms applied during casting and method of forming the same
CN1183058C (en) 1995-09-01 2005-01-05 米列姆·贝尔罗吉克公司 Artificial stabilized composition of calcium phosphate phases particularly adapted for supporting bone cell activity
US6846493B2 (en) 1995-09-01 2005-01-25 Millenium Biologix Inc. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US5758562A (en) 1995-10-11 1998-06-02 Schneider (Usa) Inc. Process for manufacturing braided composite prosthesis
US5603556A (en) 1995-11-20 1997-02-18 Technical Services And Marketing, Inc. Rail car load sensor
DE19544750A1 (en) 1995-11-30 1997-06-05 Christoph Rehberg Implantable device with internal electrode to promote tissue growth
DE69621826T2 (en) 1995-12-14 2003-01-23 Imperial College FILM OR LAYER DEPOSITION AND POWDER MANUFACTURE
US5852088A (en) 1995-12-27 1998-12-22 Exxon Research And Engineering Company Nanoporous ceramics with catalytic functionality
US5874134A (en) 1996-01-29 1999-02-23 Regents Of The University Of Minnesota Production of nanostructured materials by hypersonic plasma particle deposition
US5672242A (en) 1996-01-31 1997-09-30 Integrated Device Technology, Inc. High selectivity nitride to oxide etch process
US5772864A (en) 1996-02-23 1998-06-30 Meadox Medicals, Inc. Method for manufacturing implantable medical devices
US6441025B2 (en) 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
US6355198B1 (en) 1996-03-15 2002-03-12 President And Fellows Of Harvard College Method of forming articles including waveguides via capillary micromolding and microtransfer molding
CA2199890C (en) 1996-03-26 2002-02-05 Leonard Pinchuk Stents and stent-grafts having enhanced hoop strength and methods of making the same
US6783543B2 (en) 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US6241760B1 (en) 1996-04-26 2001-06-05 G. David Jang Intravascular stent
US20040225347A1 (en) 2000-06-05 2004-11-11 Lang G. David Intravascular stent with increasing coating retaining capacity
AU3115897A (en) 1996-04-26 1997-11-19 G. David Jang Intravascular stent
US20040106985A1 (en) 1996-04-26 2004-06-03 Jang G. David Intravascular stent
US5922021A (en) 1996-04-26 1999-07-13 Jang; G. David Intravascular stent
US5888591A (en) 1996-05-06 1999-03-30 Massachusetts Institute Of Technology Chemical vapor deposition of fluorocarbon polymer thin films
US5830480A (en) 1996-05-09 1998-11-03 The Trustees Of The University Of Pennsylvania Stabilization of sol-gel derived silica-based glass
US5951881A (en) 1996-07-22 1999-09-14 President And Fellows Of Harvard College Fabrication of small-scale cylindrical articles
EP0806211B1 (en) 1996-05-10 2002-10-23 IsoTis N.V. Implant material and process for producing it
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
US5769884A (en) 1996-06-27 1998-06-23 Cordis Corporation Controlled porosity endovascular implant
US5693928A (en) 1996-06-27 1997-12-02 International Business Machines Corporation Method for producing a diffusion barrier and polymeric article having a diffusion barrier
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5741331A (en) 1996-07-29 1998-04-21 Corvita Corporation Biostable elastomeric polymers having quaternary carbons
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
US6756060B1 (en) 1996-09-19 2004-06-29 Usbiomaterials Corp. Anti-inflammatory and antimicrobial uses for bioactive glass compositions
EP1275352A3 (en) 1996-09-20 2003-06-11 Converge Medical, Inc. Radially expanding prostheses and systems for their deployment
US6074135A (en) 1996-09-25 2000-06-13 Innovative Technologies, Inc. Coating or ablation applicator with debris recovery attachment
US5761775A (en) 1996-10-17 1998-06-09 Legome; Mark J. Mushroom and loop material closure system for high shear strength and low peel strength applications
US6387121B1 (en) 1996-10-21 2002-05-14 Inflow Dynamics Inc. Vascular and endoluminal stents with improved coatings
US6099561A (en) 1996-10-21 2000-08-08 Inflow Dynamics, Inc. Vascular and endoluminal stents with improved coatings
US5824045A (en) 1996-10-21 1998-10-20 Inflow Dynamics Inc. Vascular and endoluminal stents
US6530951B1 (en) 1996-10-24 2003-03-11 Cook Incorporated Silver implantable medical device
US6331289B1 (en) 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US6106473A (en) 1996-11-06 2000-08-22 Sts Biopolymers, Inc. Echogenic coatings
ZA9710342B (en) 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US5871437A (en) 1996-12-10 1999-02-16 Inflow Dynamics, Inc. Radioactive stent for treating blood vessels to prevent restenosis
US6780491B1 (en) 1996-12-12 2004-08-24 Micron Technology, Inc. Microstructures including hydrophilic particles
IT1289815B1 (en) 1996-12-30 1998-10-16 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS
US6013591A (en) 1997-01-16 2000-01-11 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
US5858556A (en) 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US5980551A (en) 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
AU6657098A (en) 1997-02-12 1998-08-26 Prolifix Medical, Inc. Apparatus for removal of material from stents
ES2130062B1 (en) 1997-02-19 2000-04-01 Pons Creus Joan Maria ELECTRODE SUPPORT FOR CARDIOLOGY.
WO1998036784A1 (en) 1997-02-20 1998-08-27 Cook Incorporated Coated implantable medical device
US20020133222A1 (en) 1997-03-05 2002-09-19 Das Gladwin S. Expandable stent having a plurality of interconnected expansion modules
CA2282748C (en) 1997-03-05 2007-11-20 Boston Scientific Limited Conformal laminate stent device
WO1998042277A1 (en) 1997-03-25 1998-10-01 Jang G David Intravascular stent
US5954724A (en) 1997-03-27 1999-09-21 Davidson; James A. Titanium molybdenum hafnium alloys for medical implants and devices
BR9808109A (en) 1997-03-31 2000-03-08 Neorx Corp Therapeutic smooth muscle vascular cell inhibitor
US6210715B1 (en) 1997-04-01 2001-04-03 Cap Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
US5977204A (en) 1997-04-11 1999-11-02 Osteobiologics, Inc. Biodegradable implant material comprising bioactive ceramic
US6240616B1 (en) 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US5843172A (en) 1997-04-15 1998-12-01 Advanced Cardiovascular Systems, Inc. Porous medicated stent
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
IT1292295B1 (en) 1997-04-29 1999-01-29 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT
US5879697A (en) 1997-04-30 1999-03-09 Schneider Usa Inc Drug-releasing coatings for medical devices
US5891192A (en) 1997-05-22 1999-04-06 The Regents Of The University Of California Ion-implanted protein-coated intralumenal implants
US6025036A (en) 1997-05-28 2000-02-15 The United States Of America As Represented By The Secretary Of The Navy Method of producing a film coating by matrix assisted pulsed laser deposition
GB2325934A (en) 1997-06-03 1998-12-09 Polybiomed Ltd Treating metal surfaces to enhance bio-compatibility and/or physical characteristics
US6203536B1 (en) 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
US5749809A (en) 1997-06-20 1998-05-12 Lin; Ting Fung Stepping and swinging exerciser
US20020169493A1 (en) 1997-07-10 2002-11-14 Widenhouse Christopher W. Anti-thrombogenic coatings for biomedical devices
US5817046A (en) 1997-07-14 1998-10-06 Delcath Systems, Inc. Apparatus and method for isolated pelvic perfusion
FR2766092B1 (en) 1997-07-16 1999-10-08 Centre Nat Rech Scient IMPLANTABLE DEVICE COATED WITH A POLYMER CAPABLE OF RELEASING BIOLOGICALLY ACTIVE SUBSTANCES
DE19731021A1 (en) 1997-07-18 1999-01-21 Meyer Joerg In vivo degradable metallic implant
JP3411559B2 (en) 1997-07-28 2003-06-03 マサチューセッツ・インスティチュート・オブ・テクノロジー Pyrolytic chemical vapor deposition of silicone films.
US5980564A (en) 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
US6174330B1 (en) 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US5899935A (en) 1997-08-04 1999-05-04 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US6342507B1 (en) 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
US6884429B2 (en) 1997-09-05 2005-04-26 Isotechnika International Inc. Medical devices incorporating deuterated rapamycin for controlled delivery thereof
US5972027A (en) 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6273908B1 (en) 1997-10-24 2001-08-14 Robert Ndondo-Lay Stents
US6551353B1 (en) 1997-10-28 2003-04-22 Hills, Inc. Synthetic fibers for medical use and method of making the same
US6309414B1 (en) 1997-11-04 2001-10-30 Sorin Biomedica Cardio S.P.A. Angioplasty stents
DE69842217D1 (en) 1997-11-07 2011-05-19 State University Radiopaque polymeric biomaterials
CA2308177C (en) 1997-11-07 2005-01-25 Expandable Grafts Partnership Intravascular stent and method for manufacturing an intravascular stent
NO311781B1 (en) 1997-11-13 2002-01-28 Medinol Ltd Metal multilayer stents
US6212434B1 (en) 1998-07-22 2001-04-03 Cardiac Pacemakers, Inc. Single pass lead system
US6077413A (en) 1998-02-06 2000-06-20 The Cleveland Clinic Foundation Method of making a radioactive stent
US6120660A (en) 1998-02-11 2000-09-19 Silicon Genesis Corporation Removable liner design for plasma immersion ion implantation
US6623521B2 (en) 1998-02-17 2003-09-23 Md3, Inc. Expandable stent with sliding and locking radial elements
US6139585A (en) 1998-03-11 2000-10-31 Depuy Orthopaedics, Inc. Bioactive ceramic coating and method
US6187037B1 (en) 1998-03-11 2001-02-13 Stanley Satz Metal stent containing radioactivatable isotope and method of making same
US6736849B2 (en) 1998-03-11 2004-05-18 Depuy Products, Inc. Surface-mineralized spinal implants
US7547445B2 (en) 1998-03-19 2009-06-16 Surmodics, Inc. Crosslinkable macromers
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
EP1702586B1 (en) 1998-03-30 2008-08-06 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7208011B2 (en) 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
DE19916086B4 (en) 1998-04-11 2004-11-11 Inflow Dynamics Inc. Implantable prosthesis, especially vascular prosthesis (stent)
US5980566A (en) 1998-04-11 1999-11-09 Alt; Eckhard Vascular and endoluminal stents with iridium oxide coating
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US6364856B1 (en) 1998-04-14 2002-04-02 Boston Scientific Corporation Medical device with sponge coating for controlled drug release
US20030040790A1 (en) 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US6436133B1 (en) 1998-04-15 2002-08-20 Joseph G. Furst Expandable graft
US6206916B1 (en) 1998-04-15 2001-03-27 Joseph G. Furst Coated intraluminal graft
US20020099438A1 (en) 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US6270831B2 (en) 1998-04-30 2001-08-07 Medquest Products, Inc. Method and apparatus for providing a conductive, amorphous non-stick coating
DE69935716T2 (en) 1998-05-05 2007-08-16 Boston Scientific Ltd., St. Michael STENT WITH SMOOTH ENDS
US6206283B1 (en) 1998-12-23 2001-03-27 At&T Corp. Method and apparatus for transferring money via a telephone call
US6280411B1 (en) 1998-05-18 2001-08-28 Scimed Life Systems, Inc. Localized delivery of drug agents
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
EP0966979B1 (en) 1998-06-25 2006-03-08 Biotronik AG Implantable bioresorbable support for the vascular walls, in particular coronary stent
US6153252A (en) 1998-06-30 2000-11-28 Ethicon, Inc. Process for coating stents
US6122564A (en) 1998-06-30 2000-09-19 Koch; Justin Apparatus and methods for monitoring and controlling multi-layer laser cladding
US6652581B1 (en) 1998-07-07 2003-11-25 Boston Scientific Scimed, Inc. Medical device with porous surface for controlled drug release and method of making the same
US6022812A (en) 1998-07-07 2000-02-08 Alliedsignal Inc. Vapor deposition routes to nanoporous silica
US8070796B2 (en) 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
US20020038146A1 (en) 1998-07-29 2002-03-28 Ulf Harry Expandable stent with relief cuts for carrying medicines and other materials
US20040088041A1 (en) 1999-07-20 2004-05-06 Stanford Ulf Harry Expandable stent with array of relief cuts
US20010032011A1 (en) 1999-07-20 2001-10-18 Stanford Ulf Harry Expandable stent with array of relief cuts
WO2000010622A1 (en) 1998-08-20 2000-03-02 Cook Incorporated Coated implantable medical device
US6248127B1 (en) 1998-08-21 2001-06-19 Medtronic Ave, Inc. Thromboresistant coated medical device
US7235096B1 (en) 1998-08-25 2007-06-26 Tricardia, Llc Implantable device for promoting repair of a body lumen
US6335029B1 (en) 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
IL142132A0 (en) 1998-09-23 2002-03-10 Phycogen Inc Methods and compositions for treating receptor mediated diseases
US6206915B1 (en) 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
US6245104B1 (en) 1999-02-28 2001-06-12 Inflow Dynamics Inc. Method of fabricating a biocompatible stent
US6217607B1 (en) 1998-10-20 2001-04-17 Inflow Dynamics Inc. Premounted stent delivery system for small vessels
US6293967B1 (en) 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE19855421C2 (en) 1998-11-02 2001-09-20 Alcove Surfaces Gmbh Implant
US6348960B1 (en) 1998-11-06 2002-02-19 Kimotot Co., Ltd. Front scattering film
US6214042B1 (en) 1998-11-10 2001-04-10 Precision Vascular Systems, Inc. Micro-machined stent for vessels, body ducts and the like
US6361780B1 (en) 1998-11-12 2002-03-26 Cardiac Pacemakers, Inc. Microporous drug delivery system
US20010014821A1 (en) 1998-11-16 2001-08-16 Mohamad Ike Juman Balloon catheter and stent delivery system having enhanced stent retention
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
US20020077520A1 (en) 1998-11-18 2002-06-20 Jerome Segal Device and method for dilating and irradiating a vascular segment or body passageway
US6063101A (en) 1998-11-20 2000-05-16 Precision Vascular Systems, Inc. Stent apparatus and method
CN1145632C (en) 1998-11-26 2004-04-14 因芬尼昂技术股份公司 Complex compound of element of sub-group IV
US20060178727A1 (en) 1998-12-03 2006-08-10 Jacob Richter Hybrid amorphous metal alloy stent
US20070219642A1 (en) 1998-12-03 2007-09-20 Jacob Richter Hybrid stent having a fiber or wire backbone
EP1316323A1 (en) 1998-12-31 2003-06-04 Angiotech Pharmaceuticals, Inc. Stent grafts with bioactive coatings
US6955661B1 (en) 1999-01-25 2005-10-18 Atrium Medical Corporation Expandable fluoropolymer device for delivery of therapeutic agents and method of making
US6383519B1 (en) 1999-01-26 2002-05-07 Vita Special Purpose Corporation Inorganic shaped bodies and methods for their production and use
AU2514900A (en) 1999-01-27 2000-08-18 United States Of America As Represented By The Secretary Of The Navy, The Fabrication of conductive/non-conductive nanocomposites by laser evaporation
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
DE19948783C2 (en) 1999-02-18 2001-06-13 Alcove Surfaces Gmbh Implant
US6558422B1 (en) 1999-03-26 2003-05-06 University Of Washington Structures having coated indentations
US6312457B1 (en) 1999-04-01 2001-11-06 Boston Scientific Corporation Intraluminal lining
US6325825B1 (en) 1999-04-08 2001-12-04 Cordis Corporation Stent with variable wall thickness
US6607598B2 (en) 1999-04-19 2003-08-19 Scimed Life Systems, Inc. Device for protecting medical devices during a coating process
US6368658B1 (en) 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US7371400B2 (en) 2001-01-02 2008-05-13 The General Hospital Corporation Multilayer device for tissue engineering
US6461731B1 (en) 1999-05-03 2002-10-08 Guardian Industries Corp. Solar management coating system including protective DLC
US6726712B1 (en) 1999-05-14 2004-04-27 Boston Scientific Scimed Prosthesis deployment device with translucent distal end
US6610035B2 (en) 1999-05-21 2003-08-26 Scimed Life Systems, Inc. Hydrophilic lubricity coating for medical devices comprising a hybrid top coat
US7171263B2 (en) 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
US6139913A (en) 1999-06-29 2000-10-31 National Center For Manufacturing Sciences Kinetic spray coating method and apparatus
US6504292B1 (en) 1999-07-15 2003-01-07 Agere Systems Inc. Field emitting device comprising metallized nanostructures and method for making the same
IT1307263B1 (en) 1999-08-05 2001-10-30 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT WITH RESTENOSIS ANTAGONIST ACTION, RELATED KIT AND COMPONENTS.
US6458162B1 (en) 1999-08-13 2002-10-01 Vita Special Purpose Corporation Composite shaped bodies and methods for their production and use
US6869701B1 (en) 1999-08-16 2005-03-22 Carolyn Aita Self-repairing ceramic coatings
US6287628B1 (en) 1999-09-03 2001-09-11 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6790228B2 (en) 1999-12-23 2004-09-14 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6713119B2 (en) 1999-09-03 2004-03-30 Advanced Cardiovascular Systems, Inc. Biocompatible coating for a prosthesis and a method of forming the same
EP1214108B1 (en) 1999-09-03 2007-01-10 Advanced Cardiovascular Systems, Inc. A porous prosthesis and a method of depositing substances into the pores
US6379381B1 (en) 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
JP2001098308A (en) 1999-09-24 2001-04-10 Asahi Optical Co Ltd Porous calcium phosphate series compound/metal composite sintered body and producing method
US6845212B2 (en) 1999-10-08 2005-01-18 3M Innovative Properties Company Optical element having programmed optical structures
DE19950386A1 (en) 1999-10-19 2001-05-10 Miladin Lazarov Biocompatible item
DE19951477A1 (en) 1999-10-26 2001-05-03 Biotronik Mess & Therapieg Stent
US6733513B2 (en) 1999-11-04 2004-05-11 Advanced Bioprosthetic Surfaces, Ltd. Balloon catheter having metal balloon and method of making same
US6761736B1 (en) 1999-11-10 2004-07-13 St. Jude Medical, Inc. Medical article with a diamond-like carbon coated polymer
AU2004202073B2 (en) 1999-11-17 2007-01-04 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
WO2001035928A1 (en) 1999-11-17 2001-05-25 Microchips, Inc. Microfabricated devices for the delivery of molecules into a carrier fluid
US6337076B1 (en) 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
US6936066B2 (en) 1999-11-19 2005-08-30 Advanced Bio Prosthetic Surfaces, Ltd. Complaint implantable medical devices and methods of making same
US6849085B2 (en) 1999-11-19 2005-02-01 Advanced Bio Prosthetic Surfaces, Ltd. Self-supporting laminated films, structural materials and medical devices manufactured therefrom and method of making same
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6416820B1 (en) 1999-11-19 2002-07-09 Epion Corporation Method for forming carbonaceous hard film
US6379383B1 (en) 1999-11-19 2002-04-30 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal device exhibiting improved endothelialization and method of manufacture thereof
US7195641B2 (en) 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US7235092B2 (en) 1999-11-19 2007-06-26 Advanced Bio Prosthetic Surfaces, Ltd. Guidewires and thin film catheter-sheaths and method of making same
US7335426B2 (en) 1999-11-19 2008-02-26 Advanced Bio Prosthetic Surfaces, Ltd. High strength vacuum deposited nitinol alloy films and method of making same
US6537310B1 (en) 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US20060013850A1 (en) 1999-12-03 2006-01-19 Domb Abraham J Electropolymerizable monomers and polymeric coatings on implantable devices prepared therefrom
US6251136B1 (en) 1999-12-08 2001-06-26 Advanced Cardiovascular Systems, Inc. Method of layering a three-coated stent using pharmacological and polymeric agents
US6479418B2 (en) 1999-12-16 2002-11-12 Isotis N.V. Porous ceramic body
US6613432B2 (en) 1999-12-22 2003-09-02 Biosurface Engineering Technologies, Inc. Plasma-deposited coatings, devices and methods
US6908624B2 (en) 1999-12-23 2005-06-21 Advanced Cardiovascular Systems, Inc. Coating for implantable devices and a method of forming the same
US6471721B1 (en) 1999-12-30 2002-10-29 Advanced Cardiovascular Systems, Inc. Vascular stent having increased radiopacity and method for making same
US6967023B1 (en) 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
ATE460951T1 (en) 2000-01-25 2010-04-15 Edwards Lifesciences Corp RELEASE SYSTEMS FOR THE TREATMENT OF RESTENOSIS AND ANASTOMOTIC INTIMAL HYPERPLASIA
JP2005503178A (en) 2000-01-25 2005-02-03 ボストン サイエンティフィック リミテッド Manufacturing medical devices by vapor deposition
US6367412B1 (en) 2000-02-17 2002-04-09 Applied Materials, Inc. Porous ceramic liner for a plasma source
US6440503B1 (en) 2000-02-25 2002-08-27 Scimed Life Systems, Inc. Laser deposition of elements onto medical devices
CA2337565A1 (en) 2000-02-25 2001-08-25 Cordis Corporation Use of cladribine on a stent to prevent restenosis
EP1132058A1 (en) 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Intravascular prothesis
US20160287708A9 (en) 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
WO2001068270A2 (en) 2000-03-16 2001-09-20 Volkswagen Aktiengesellschaft Method for removing minor lacquer imperfections
US6695865B2 (en) 2000-03-20 2004-02-24 Advanced Bio Prosthetic Surfaces, Ltd. Embolic protection device
US6315708B1 (en) 2000-03-31 2001-11-13 Cordis Corporation Stent with self-expanding end sections
US6527801B1 (en) 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
US7066234B2 (en) 2001-04-25 2006-06-27 Alcove Surfaces Gmbh Stamping tool, casting mold and methods for structuring a surface of a work piece
US6327504B1 (en) 2000-05-10 2001-12-04 Thoratec Corporation Transcutaneous energy transfer with circuitry arranged to avoid overheating
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
US9566148B2 (en) 2000-05-12 2017-02-14 Vactronix Scientific, Inc. Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same
US6395325B1 (en) 2000-05-16 2002-05-28 Scimed Life Systems, Inc. Porous membranes
EP1359865B1 (en) 2000-05-19 2006-11-22 Advanced Bio Prosthetic Surfaces, Ltd. Methods and apparatus for manufacturing an intravascular stent
US8252044B1 (en) 2000-11-17 2012-08-28 Advanced Bio Prosthestic Surfaces, Ltd. Device for in vivo delivery of bioactive agents and method of manufacture thereof
KR100360364B1 (en) 2000-05-22 2002-11-13 주식회사 정성메디칼 A metal stent for installation in the coronary artery
US20040211362A1 (en) 2000-05-31 2004-10-28 Daniel Castro System for coating a stent
US6395326B1 (en) 2000-05-31 2002-05-28 Advanced Cardiovascular Systems, Inc. Apparatus and method for depositing a coating onto a surface of a prosthesis
US6986818B2 (en) 2000-06-02 2006-01-17 The Regents Of The University Of California Method for producing nanostructured metal-oxides
JP4656697B2 (en) 2000-06-16 2011-03-23 キヤノンアネルバ株式会社 High frequency sputtering equipment
US6627974B2 (en) 2000-06-19 2003-09-30 Nichia Corporation Nitride semiconductor substrate and method for manufacturing the same, and nitride semiconductor device using nitride semiconductor substrate
US6585765B1 (en) 2000-06-29 2003-07-01 Advanced Cardiovascular Systems, Inc. Implantable device having substances impregnated therein and a method of impregnating the same
US20020077693A1 (en) 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
US20030077200A1 (en) 2000-07-07 2003-04-24 Craig Charles H. Enhanced radiopaque alloy stent
US20020144757A1 (en) 2000-07-07 2002-10-10 Craig Charles Horace Stainless steel alloy with improved radiopaque characteristics
US20030018380A1 (en) 2000-07-07 2003-01-23 Craig Charles H. Platinum enhanced alloy and intravascular or implantable medical devices manufactured therefrom
US6676989B2 (en) 2000-07-10 2004-01-13 Epion Corporation Method and system for improving the effectiveness of medical stents by the application of gas cluster ion beam technology
US6709451B1 (en) 2000-07-14 2004-03-23 Norman Noble, Inc. Channeled vascular stent apparatus and method
NZ505774A (en) 2000-07-17 2002-12-20 Ind Res Ltd Oxalate stabilised titania solutions and coating compositions and catalysts formed therefrom
AU2001277007A1 (en) 2000-07-19 2002-01-30 Regents Of The University Of Minnesota Apparatus and method for synthesizing films and coatings by focused particle beam deposition
US20050113798A1 (en) 2000-07-21 2005-05-26 Slater Charles R. Methods and apparatus for treating the interior of a blood vessel
DE10040897B4 (en) 2000-08-18 2006-04-13 TransMIT Gesellschaft für Technologietransfer mbH Nanoscale porous fibers of polymeric materials
US6399528B1 (en) 2000-09-01 2002-06-04 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Porous aluminum oxide structures and processes for their production
US6390967B1 (en) 2000-09-14 2002-05-21 Xoft Microtube, Inc. Radiation for inhibiting hyperplasia after intravascular intervention
US7101391B2 (en) 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US7402173B2 (en) 2000-09-18 2008-07-22 Boston Scientific Scimed, Inc. Metal stent with surface layer of noble metal oxide and method of fabrication
US6478815B1 (en) 2000-09-18 2002-11-12 Inflow Dynamics Inc. Vascular and endoluminal stents
US20020062154A1 (en) 2000-09-22 2002-05-23 Ayers Reed A. Non-uniform porosity tissue implant
US6805898B1 (en) 2000-09-28 2004-10-19 Advanced Cardiovascular Systems, Inc. Surface features of an implantable medical device
US6254632B1 (en) 2000-09-28 2001-07-03 Advanced Cardiovascular Systems, Inc. Implantable medical device having protruding surface structures for drug delivery and cover attachment
US6953560B1 (en) 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US6716444B1 (en) 2000-09-28 2004-04-06 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US20020111590A1 (en) 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
US20020051730A1 (en) 2000-09-29 2002-05-02 Stanko Bodnar Coated medical devices and sterilization thereof
US7261735B2 (en) 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
KR200227881Y1 (en) 2000-09-29 2001-06-15 주식회사이오니아테크놀로지 Image storag system of dental diagnosis
US6746773B2 (en) 2000-09-29 2004-06-08 Ethicon, Inc. Coatings for medical devices
DE60112318D1 (en) 2000-10-16 2005-09-01 Conor Medsystems Inc EXPANDABLE MEDICAL DEVICE FOR DELIVERING A REMEDY
WO2002033019A1 (en) 2000-10-16 2002-04-25 3M Innovative Properties Company Method of making ceramic aggregate particles
US6506437B1 (en) 2000-10-17 2003-01-14 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device having depots formed in a surface thereof
US6558733B1 (en) 2000-10-26 2003-05-06 Advanced Cardiovascular Systems, Inc. Method for etching a micropatterned microdepot prosthesis
US6663664B1 (en) 2000-10-26 2003-12-16 Advanced Cardiovascular Systems, Inc. Self-expanding stent with time variable radial force
US6365222B1 (en) 2000-10-27 2002-04-02 Siemens Westinghouse Power Corporation Abradable coating applied with cold spray technique
US6758859B1 (en) 2000-10-30 2004-07-06 Kenny L. Dang Increased drug-loading and reduced stress drug delivery device
US6918927B2 (en) 2000-10-31 2005-07-19 Cook Incorporated Coated implantable medical device
DE10055686A1 (en) 2000-11-03 2002-05-08 Biotronik Mess & Therapieg Device for influencing cell proliferation mechanisms in vessels of the human or animal body
US8372139B2 (en) 2001-02-14 2013-02-12 Advanced Bio Prosthetic Surfaces, Ltd. In vivo sensor and method of making same
US8062098B2 (en) 2000-11-17 2011-11-22 Duescher Wayne O High speed flat lapping platen
US6517888B1 (en) 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
US6638246B1 (en) 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
NL1016779C2 (en) 2000-12-02 2002-06-04 Cornelis Johannes Maria V Rijn Mold, method for manufacturing precision products with the aid of a mold, as well as precision products, in particular microsieves and membrane filters, manufactured with such a mold.
DE10061057A1 (en) 2000-12-08 2002-06-13 Pharmed Holding Gmbh Chip systems for the controlled emission of chemically sensitive substances
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US20040117005A1 (en) 2000-12-15 2004-06-17 Nagarada Gadde Badari Narayan Stent with drug-delivery system
DE10064596A1 (en) 2000-12-18 2002-06-20 Biotronik Mess & Therapieg Application of a marker element to an implant, especially a stent, comprises introducing a solidifiable material into a recess and solidifying the material in the recess
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
US20040030377A1 (en) 2001-10-19 2004-02-12 Alexander Dubson Medicated polymer-coated stent assembly
ATE369817T1 (en) 2000-12-22 2007-09-15 Avantec Vascular Corp DEVICE FOR DELIVERING THERAPEUTIC ACTIVE INGREDIENTS
US7083642B2 (en) 2000-12-22 2006-08-01 Avantec Vascular Corporation Delivery of therapeutic capable agents
US6471980B2 (en) 2000-12-22 2002-10-29 Avantec Vascular Corporation Intravascular delivery of mycophenolic acid
US20030033007A1 (en) 2000-12-22 2003-02-13 Avantec Vascular Corporation Methods and devices for delivery of therapeutic capable agents with variable release profile
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US6398806B1 (en) 2000-12-26 2002-06-04 Scimed Life Systems, Inc. Monolayer modification to gold coated stents to reduce adsorption of protein
US6913617B1 (en) 2000-12-27 2005-07-05 Advanced Cardiovascular Systems, Inc. Method for creating a textured surface on an implantable medical device
US6663662B2 (en) 2000-12-28 2003-12-16 Advanced Cardiovascular Systems, Inc. Diffusion barrier layer for implantable devices
US6635082B1 (en) 2000-12-29 2003-10-21 Advanced Cardiovascular Systems Inc. Radiopaque stent
US6641607B1 (en) 2000-12-29 2003-11-04 Advanced Cardiovascular Systems, Inc. Double tube stent
US20020087123A1 (en) 2001-01-02 2002-07-04 Hossainy Syed F.A. Adhesion of heparin-containing coatings to blood-contacting surfaces of medical devices
US6544582B1 (en) 2001-01-05 2003-04-08 Advanced Cardiovascular Systems, Inc. Method and apparatus for coating an implantable device
CA2432438C (en) 2001-01-09 2011-04-26 Microchips, Inc. Flexible microchip devices for ophthalmic and other applications
US6583048B2 (en) 2001-01-17 2003-06-24 Air Products And Chemicals, Inc. Organosilicon precursors for interlayer dielectric films with low dielectric constants
US6752829B2 (en) 2001-01-30 2004-06-22 Scimed Life Systems, Inc. Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
JP2002308683A (en) 2001-01-31 2002-10-23 Toshiba Ceramics Co Ltd Ceramic member with roughened surface and method for manufacturing the same
US6964680B2 (en) 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
US6767360B1 (en) 2001-02-08 2004-07-27 Inflow Dynamics Inc. Vascular stent with composite structure for magnetic reasonance imaging capabilities
DE10106186A1 (en) 2001-02-10 2002-08-14 Oxeno Olefinchemie Gmbh Process for the condensation of aldehydes with ketones by means of a multi-phase reaction
DE10127011A1 (en) 2001-06-05 2002-12-12 Jomed Gmbh Implant used for treating vascular narrowing or occlusion, especially for controlling restenosis contains FK506 in chemically bound or physically fixed form
DE10107339A1 (en) 2001-02-16 2002-09-05 Jomed Gmbh Implant used for treating vascular narrowing or occlusion, especially for controlling restenosis contains FK506 in chemically bound or physically fixed form
NZ540000A (en) 2001-02-16 2007-05-31 Abbott Lab Vascular Entpr Ltd Implants with tacrolimus
US6679911B2 (en) 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6998060B2 (en) 2001-03-01 2006-02-14 Cordis Corporation Flexible stent and method of manufacture
ATE322918T1 (en) 2001-03-02 2006-04-15 Univ Laval PLASMA SURFACE GRAFTING PROCESS FOR THROMBOGENICITY REDUCTION
WO2002069848A2 (en) 2001-03-06 2002-09-12 Board Of Regents, The University Of Texas System Apparatus for stent deployment with delivery of bioactive agents
US20020133225A1 (en) 2001-03-13 2002-09-19 Gordon Lucas S. Methods and apparatuses for delivering a medical agent to a medical implant
WO2002074431A1 (en) 2001-03-21 2002-09-26 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften Hollow spheres from layered precursor deposition on sacrificial colloidal core particles
US6709622B2 (en) 2001-03-23 2004-03-23 Romain Billiet Porous nanostructures and method of fabrication thereof
US20020138136A1 (en) 2001-03-23 2002-09-26 Scimed Life Systems, Inc. Medical device having radio-opacification and barrier layers
US6780424B2 (en) 2001-03-30 2004-08-24 Charles David Claude Controlled morphologies in polymer drug for release of drugs from polymer films
US6673105B1 (en) 2001-04-02 2004-01-06 Advanced Cardiovascular Systems, Inc. Metal prosthesis coated with expandable ePTFE
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
ES2173817B1 (en) 2001-04-16 2003-10-16 Fundacion Inasmet METHOD FOR THE MANUFACTURE OF ENDO-OSEOS IMPLANTS OR MEDICAL PROTESIS THROUGH THE IONIC IMPLEMENTATION TECHNIQUE.
US7048939B2 (en) 2001-04-20 2006-05-23 The Board Of Trustees Of The Leland Stanford Junior University Methods for the inhibition of neointima formation
US7056339B2 (en) 2001-04-20 2006-06-06 The Board Of Trustees Of The Leland Stanford Junior University Drug delivery platform
WO2002085253A1 (en) 2001-04-20 2002-10-31 The Board Of Trustees Of The Leland Stanford Junior University Drug delivery platform and methods for the inhibition of neointima formation
US6712845B2 (en) 2001-04-24 2004-03-30 Advanced Cardiovascular Systems, Inc. Coating for a stent and a method of forming the same
US6915964B2 (en) 2001-04-24 2005-07-12 Innovative Technology, Inc. System and process for solid-state deposition and consolidation of high velocity powder particles using thermal plastic deformation
US7232460B2 (en) 2001-04-25 2007-06-19 Xillus, Inc. Nanodevices, microdevices and sensors on in-vivo structures and method for the same
US6660034B1 (en) 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
EP1656961B1 (en) 2001-05-02 2015-08-05 InFlow Dynamics, Inc. Immuno-tolerant stent with surface microstructure
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US8182527B2 (en) 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
WO2002089702A2 (en) 2001-05-09 2002-11-14 Epion Corporation Method and system for improving the effectiveness of artificial joints by the application of gas cluster ion beam technology
US6656506B1 (en) 2001-05-09 2003-12-02 Advanced Cardiovascular Systems, Inc. Microparticle coated medical device
US7105199B2 (en) 2001-05-11 2006-09-12 Exogenesis Corporation Methods of adhering drugs to the surface of medical devices through ion beam surface modification
US7247338B2 (en) 2001-05-16 2007-07-24 Regents Of The University Of Minnesota Coating medical devices
US6973718B2 (en) 2001-05-30 2005-12-13 Microchips, Inc. Methods for conformal coating and sealing microchip reservoir devices
US7862495B2 (en) 2001-05-31 2011-01-04 Advanced Cardiovascular Systems, Inc. Radiation or drug delivery source with activity gradient to minimize edge effects
US6712844B2 (en) 2001-06-06 2004-03-30 Advanced Cardiovascular Systems, Inc. MRI compatible stent
EP1399200B2 (en) 2001-06-11 2014-07-02 Boston Scientific Limited COMPOSITE ePTFE/TEXTILE PROSTHESIS
US7201940B1 (en) 2001-06-12 2007-04-10 Advanced Cardiovascular Systems, Inc. Method and apparatus for thermal spray processing of medical devices
US6527938B2 (en) 2001-06-21 2003-03-04 Syntheon, Llc Method for microporous surface modification of implantable metallic medical articles
US6585755B2 (en) 2001-06-29 2003-07-01 Advanced Cardiovascular Polymeric stent suitable for imaging by MRI and fluoroscopy
US6676987B2 (en) 2001-07-02 2004-01-13 Scimed Life Systems, Inc. Coating a medical appliance with a bubble jet printing head
US20030050687A1 (en) 2001-07-03 2003-03-13 Schwade Nathan D. Biocompatible stents and method of deployment
EP1273314A1 (en) 2001-07-06 2003-01-08 Terumo Kabushiki Kaisha Stent
US6715640B2 (en) 2001-07-09 2004-04-06 Innovative Technology, Inc. Powder fluidizing devices and portable powder-deposition apparatus for coating and spray forming
ES2266148T5 (en) 2001-07-20 2012-11-06 Sorin Biomedica Cardio S.R.L. Stent
EP1416884A4 (en) 2001-07-26 2007-03-07 Avantec Vascular Corp Delivery of therapeutic capable agents
US6979346B1 (en) 2001-08-08 2005-12-27 Advanced Cardiovascular Systems, Inc. System and method for improved stent retention
JP4151884B2 (en) 2001-08-08 2008-09-17 独立行政法人理化学研究所 Method for producing a material in which a composite metal oxide nanomaterial is formed on a solid surface
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
EP1437989A2 (en) 2001-08-27 2004-07-21 James C. Thomas, Jr. Expandable implant for partial disc replacement and reinforcement of a disc partially removed in a discectomy and for reduction and maintenance of alignment of cancellous bone fractures and methods and apparatuses for same.
US20060224234A1 (en) 2001-08-29 2006-10-05 Swaminathan Jayaraman Drug eluting structurally variable stent
GB0121980D0 (en) 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
US20030047505A1 (en) 2001-09-13 2003-03-13 Grimes Craig A. Tubular filter with branched nanoporous membrane integrated with a support and method of producing same
WO2003024357A2 (en) 2001-09-14 2003-03-27 Martin Francis J Microfabricated nanopore device for sustained release of therapeutic agent
US20030158598A1 (en) 2001-09-17 2003-08-21 Control Delivery Systems, Inc. System for sustained-release delivery of anti-inflammatory agents from a coated medical device
US6669980B2 (en) 2001-09-18 2003-12-30 Scimed Life Systems, Inc. Method for spray-coating medical devices
US20030060873A1 (en) 2001-09-19 2003-03-27 Nanomedical Technologies, Inc. Metallic structures incorporating bioactive materials and methods for creating the same
US7776379B2 (en) 2001-09-19 2010-08-17 Medlogics Device Corporation Metallic structures incorporating bioactive materials and methods for creating the same
CA2458828A1 (en) 2001-09-24 2003-05-01 James J. Barry Optimized dosing for drug coated stents
US6827737B2 (en) 2001-09-25 2004-12-07 Scimed Life Systems, Inc. EPTFE covering for endovascular prostheses and method of manufacture
US7195640B2 (en) 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US6753071B1 (en) 2001-09-27 2004-06-22 Advanced Cardiovascular Systems, Inc. Rate-reducing membrane for release of an agent
WO2003028660A2 (en) 2001-10-04 2003-04-10 Case Western Reserve University Drug delivery devices and methods
DE10150995A1 (en) 2001-10-08 2003-04-10 Biotronik Mess & Therapieg Implant e.g. a stent, comprises a decomposable substance which allows contact between the cell proliferation inhibitor and the stent surroundings only after a specified time
US6709397B2 (en) 2001-10-16 2004-03-23 Envisioneering, L.L.C. Scanning probe
WO2003055414A1 (en) 2001-10-18 2003-07-10 Advanced Stent Technologies, Inc. Stent for vessel support, coverage and side branch accessibility
US8562664B2 (en) 2001-10-25 2013-10-22 Advanced Cardiovascular Systems, Inc. Manufacture of fine-grained material for use in medical devices
DE10152055A1 (en) 2001-10-25 2003-05-08 Nttf Gmbh Mechanically and thermodynamically stable amorphous carbon layers for temperature-sensitive surfaces
EP1308179A1 (en) 2001-10-30 2003-05-07 Boehringer Ingelheim Pharma GmbH & Co.KG Improved endoprosthetic device
US20030083614A1 (en) 2001-10-30 2003-05-01 Boehringer Ingelheim Pharma Kg Controlled release endoprosthetic device
US6887578B2 (en) 2001-10-30 2005-05-03 Massachusetts Institute Of Technology Fluorocarbon-organosilicon copolymers and coatings prepared by hot-filament chemical vapor deposition
US6939376B2 (en) 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20030088307A1 (en) 2001-11-05 2003-05-08 Shulze John E. Potent coatings for stents
US6764709B2 (en) 2001-11-08 2004-07-20 Scimed Life Systems, Inc. Method for making and measuring a coating on the surface of a medical device using an ultraviolet laser
US6807440B2 (en) 2001-11-09 2004-10-19 Scimed Life Systems, Inc. Ceramic reinforcement members for MRI devices
EP1310242A1 (en) 2001-11-13 2003-05-14 SORIN BIOMEDICA CARDIO S.p.A. Carrier and kit for endoluminal delivery of active principles
CN1301757C (en) 2001-11-27 2007-02-28 多喜兰株式会社 Implant material and process for producing the same
US20030104028A1 (en) 2001-11-29 2003-06-05 Hossainy Syed F.A. Rate limiting barriers for implantable devices and methods for fabrication thereof
US6465052B1 (en) 2001-11-30 2002-10-15 Nanotek Instruments, Inc. Method for production of nano-porous coatings
US7014654B2 (en) 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
DE60106962T2 (en) 2001-12-12 2005-04-28 Hehrlein, Christoph, Dr. Porous metallic stent with a coating
US6752826B2 (en) 2001-12-14 2004-06-22 Thoratec Corporation Layered stent-graft and methods of making the same
US6866805B2 (en) 2001-12-27 2005-03-15 Advanced Cardiovascular Systems, Inc. Hybrid intravascular stent
US7575759B2 (en) 2002-01-02 2009-08-18 The Regents Of The University Of Michigan Tissue engineering scaffolds
DE10200387B4 (en) 2002-01-08 2009-11-26 Translumina Gmbh stent
US6506972B1 (en) 2002-01-22 2003-01-14 Nanoset, Llc Magnetically shielded conductor
MXPA04006731A (en) 2002-01-10 2004-10-04 Novartis Ag Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof.
US6949590B2 (en) 2002-01-10 2005-09-27 University Of Washington Hydrogels formed by non-covalent linkages
US6864418B2 (en) 2002-12-18 2005-03-08 Nanoset, Llc Nanomagnetically shielded substrate
US6906256B1 (en) 2002-01-22 2005-06-14 Nanoset, Llc Nanomagnetic shielding assembly
WO2003061755A2 (en) 2002-01-22 2003-07-31 Nanoset, Llc Nanomagnetically shielded substrate
US7371582B2 (en) 2002-01-23 2008-05-13 Boditechmed Inc. Lateral flow quantitative assay method and strip and laser-induced fluorescence detection device therefor
US7060089B2 (en) 2002-01-23 2006-06-13 Boston Scientific Scimed, Inc. Multi-layer stent
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US20030153901A1 (en) 2002-02-08 2003-08-14 Atrium Medical Corporation Drug delivery panel
US20030153971A1 (en) 2002-02-14 2003-08-14 Chandru Chandrasekaran Metal reinforced biodegradable intraluminal stents
US20040029706A1 (en) 2002-02-14 2004-02-12 Barrera Enrique V. Fabrication of reinforced composite material comprising carbon nanotubes, fullerenes, and vapor-grown carbon fibers for thermal barrier materials, structural ceramics, and multifunctional nanocomposite ceramics
ATE478696T1 (en) 2002-02-15 2010-09-15 Gilead Palo Alto Inc POLYMER COATING FOR MEDICAL DEVICES
AU2003217835A1 (en) 2002-02-27 2003-09-09 University Of Virginia Patent Foundation Methods for making implantable medical devices having microstructures
US20030170605A1 (en) 2002-03-11 2003-09-11 Egan Visual Inc. Vapor deposited writing surfaces
US6743463B2 (en) 2002-03-28 2004-06-01 Scimed Life Systems, Inc. Method for spray-coating a medical device having a tubular wall such as a stent
EP1348402A1 (en) 2002-03-29 2003-10-01 Advanced Laser Applications Holding S.A. Intraluminal endoprosthesis, radially expandable, perforated for drug delivery
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7691461B1 (en) 2002-04-01 2010-04-06 Advanced Cardiovascular Systems, Inc. Hybrid stent and method of making
US20030211135A1 (en) 2002-04-11 2003-11-13 Greenhalgh Skott E. Stent having electrospun covering and method
JP3714471B2 (en) 2002-04-24 2005-11-09 学校法人慶應義塾 Medical covering material
US20030204168A1 (en) 2002-04-30 2003-10-30 Gjalt Bosma Coated vascular devices
US7008979B2 (en) 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
WO2003092791A2 (en) 2002-05-02 2003-11-13 Scimed Life Systems, Inc. Energetically-controlled delivery of biologically active material from an implanted medical device
US7122048B2 (en) 2002-05-03 2006-10-17 Scimed Life Systems, Inc. Hypotube endoluminal device
GB0210786D0 (en) 2002-05-10 2002-06-19 Plasma Coatings Ltd Orthopaedic and dental implants
DE60303705T2 (en) 2002-05-14 2006-10-19 Terumo K.K. Coated stent for the release of active substances
JP2005525911A (en) 2002-05-20 2005-09-02 オーバス メディカル テクノロジーズ インク. Implantable drug eluting medical device
US20040000540A1 (en) 2002-05-23 2004-01-01 Soboyejo Winston O. Laser texturing of surfaces for biomedical implants
US7048767B2 (en) 2002-06-11 2006-05-23 Spire Corporation Nano-crystalline, homo-metallic, protective coatings
US8211455B2 (en) 2002-06-19 2012-07-03 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled delivery of a therapeutic agent
US20040002755A1 (en) 2002-06-28 2004-01-01 Fischell David R. Method and apparatus for treating vulnerable coronary plaques using drug-eluting stents
US7314484B2 (en) 2002-07-02 2008-01-01 The Foundry, Inc. Methods and devices for treating aneurysms
US7159163B2 (en) 2002-07-08 2007-01-02 Qualcomm Incorporated Feedback for data transmissions
US20040133270A1 (en) 2002-07-08 2004-07-08 Axel Grandt Drug eluting stent and methods of manufacture
US8337893B2 (en) 2002-07-10 2012-12-25 Florida Research Foundation, Inc, University Of Sol-gel derived bioactive glass polymer composite
WO2004006983A2 (en) 2002-07-11 2004-01-22 University Of Virginia Patent Foundation Expandable body having deployable microstructures and related methods
AU2003249017A1 (en) 2002-07-11 2004-02-02 Setagon, Inc. Methods and apparatuses for repairing aneurysms
US20050096731A1 (en) 2002-07-11 2005-05-05 Kareen Looi Cell seeded expandable body
ATE495769T1 (en) 2002-07-12 2011-02-15 Cook Inc COATED MEDICAL DEVICE
DE50202547D1 (en) 2002-07-24 2005-04-28 Zimmer Gmbh Winterthur Method of making an implant and method of decontaminating a jet particle treated surface
EP1539041A1 (en) 2002-07-25 2005-06-15 Avantec Vascular Corporation Devices delivering therapeutic agents and methods regarding the same
US6974805B2 (en) 2002-08-01 2005-12-13 Min Hu Configuration of glycosaminoglycans
US7745532B2 (en) 2002-08-02 2010-06-29 Cambridge Polymer Group, Inc. Systems and methods for controlling and forming polymer gels
US7255710B2 (en) 2002-08-06 2007-08-14 Icon Medical Corp. Helical stent with micro-latches
US6962822B2 (en) 2002-08-07 2005-11-08 International Business Machines Corporation Discrete nano-textured structures in biomolecular arrays, and method of use
US7029495B2 (en) 2002-08-28 2006-04-18 Scimed Life Systems, Inc. Medical devices and methods of making the same
AU2003270070A1 (en) 2002-09-04 2004-03-29 Reva Medical, Inc. A slide and lock stent and method of manufacture from a single piece shape
US7758636B2 (en) 2002-09-20 2010-07-20 Innovational Holdings Llc Expandable medical device with openings for delivery of multiple beneficial agents
EP1402849B2 (en) 2002-09-20 2011-03-16 Abbott Laboratories Vascular Enterprises Limited Stent with rough surface and its manufacturing method
US7001422B2 (en) 2002-09-23 2006-02-21 Cordis Neurovascular, Inc Expandable stent and delivery system
US6915796B2 (en) 2002-09-24 2005-07-12 Chien-Min Sung Superabrasive wire saw and associated methods of manufacture
US20040059409A1 (en) * 2002-09-24 2004-03-25 Stenzel Eric B. Method of applying coatings to a medical device
US7261752B2 (en) 2002-09-24 2007-08-28 Chien-Min Sung Molten braze-coated superabrasive particles and associated methods
US7060051B2 (en) 2002-09-24 2006-06-13 Scimed Life Systems, Inc. Multi-balloon catheter with hydrogel coating
US6830598B1 (en) 2002-09-24 2004-12-14 Chien-Min Sung Molten braze coated superabrasive particles and associated methods
JP2006500996A (en) 2002-09-26 2006-01-12 エンドバスキュラー デバイセス インコーポレイテッド Apparatus and method for delivering mitomycin via an eluting biocompatible implantable medical device
AU2003272710B2 (en) 2002-09-26 2008-05-15 Vactronix Scientific, Llc Implantable materials having engineered surfaces and method of making same
US6971813B2 (en) 2002-09-27 2005-12-06 Labcoat, Ltd. Contact coating of prostheses
US7976936B2 (en) 2002-10-11 2011-07-12 University Of Connecticut Endoprostheses
US7794494B2 (en) 2002-10-11 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices
EP2260882B1 (en) 2002-10-11 2020-03-04 Boston Scientific Limited Implantable medical devices
EP1553896B1 (en) 2002-10-22 2009-09-09 Medtronic Vascular, Inc. Stent with eccentric coating
US20040088038A1 (en) 2002-10-30 2004-05-06 Houdin Dehnad Porous metal for drug-loaded stents
SE0203224D0 (en) 2002-10-31 2002-10-31 Cerbio Tech Ab Method of making structured ceramic coatings and coated devices prepared with the method
US20040086674A1 (en) 2002-11-01 2004-05-06 Holman Thomas J. Laser sintering process and devices made therefrom
WO2004043298A1 (en) 2002-11-07 2004-05-27 Abbott Laboratories Prosthesis having varied concentration of beneficial agent
US8221495B2 (en) 2002-11-07 2012-07-17 Abbott Laboratories Integration of therapeutic agent into a bioerodible medical device
US20040142014A1 (en) 2002-11-08 2004-07-22 Conor Medsystems, Inc. Method and apparatus for reducing tissue damage after ischemic injury
CA2513721C (en) 2002-11-08 2013-04-16 Conor Medsystems, Inc. Method and apparatus for reducing tissue damage after ischemic injury
US20040143321A1 (en) 2002-11-08 2004-07-22 Conor Medsystems, Inc. Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
US7169178B1 (en) 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
US20060121080A1 (en) 2002-11-13 2006-06-08 Lye Whye K Medical devices having nanoporous layers and methods for making the same
US9770349B2 (en) 2002-11-13 2017-09-26 University Of Virginia Patent Foundation Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
JP2006514848A (en) 2002-11-13 2006-05-18 セタゴン インコーポレーティッド Medical device having porous layer and method for producing the same
US20050070989A1 (en) 2002-11-13 2005-03-31 Whye-Kei Lye Medical devices having porous layers and methods for making the same
US8449601B2 (en) 2002-11-19 2013-05-28 Boston Scientific Scimed, Inc. Medical devices
US6923829B2 (en) * 2002-11-25 2005-08-02 Advanced Bio Prosthetic Surfaces, Ltd. Implantable expandable medical devices having regions of differential mechanical properties and methods of making same
JP4119230B2 (en) 2002-11-26 2008-07-16 株式会社 日立ディスプレイズ Display device
US7491234B2 (en) 2002-12-03 2009-02-17 Boston Scientific Scimed, Inc. Medical devices for delivery of therapeutic agents
JP2004188314A (en) 2002-12-11 2004-07-08 Kawasaki Heavy Ind Ltd Composite substrate having hydrophilic surface
US7371256B2 (en) 2002-12-16 2008-05-13 Poly-Med, Inc Composite vascular constructs with selectively controlled properties
US7666216B2 (en) 2002-12-24 2010-02-23 Novostent Corporation Delivery catheter for ribbon-type prosthesis and methods of use
US7846198B2 (en) 2002-12-24 2010-12-07 Novostent Corporation Vascular prosthesis and methods of use
US20050165469A1 (en) 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US6725901B1 (en) 2002-12-27 2004-04-27 Advanced Cardiovascular Systems, Inc. Methods of manufacture of fully consolidated or porous medical devices
US6803070B2 (en) 2002-12-30 2004-10-12 Scimed Life Systems, Inc. Apparatus and method for embedding nanoparticles in polymeric medical devices
US7105018B1 (en) 2002-12-30 2006-09-12 Advanced Cardiovascular Systems, Inc. Drug-eluting stent cover and method of use
US6896697B1 (en) 2002-12-30 2005-05-24 Advanced Cardiovascular Systems, Inc. Intravascular stent
CA2511486A1 (en) 2002-12-30 2004-07-22 Angiotech International Ag Tissue reactive compounds and compositions and uses thereof
US20040236415A1 (en) 2003-01-02 2004-11-25 Richard Thomas Medical devices having drug releasing polymer reservoirs
US7169177B2 (en) 2003-01-15 2007-01-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20040143317A1 (en) 2003-01-17 2004-07-22 Stinson Jonathan S. Medical devices
KR100495875B1 (en) 2003-01-18 2005-06-16 사회복지법인 삼성생명공익재단 Stent for percutaneous coronary intervention coated with drugs for the prevention of vascular restenosis
GB2397233A (en) 2003-01-20 2004-07-21 Julie Gold Biomedical device with bioerodable coating
US6852122B2 (en) 2003-01-23 2005-02-08 Cordis Corporation Coated endovascular AAA device
US6918929B2 (en) 2003-01-24 2005-07-19 Medtronic Vascular, Inc. Drug-polymer coated stent with pegylated styrenic block copolymers
WO2004069169A2 (en) 2003-01-31 2004-08-19 Scimed Life Systems, Inc. Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same
US7311727B2 (en) 2003-02-05 2007-12-25 Board Of Trustees Of The University Of Arkansas Encased stent
US20080038146A1 (en) 2003-02-10 2008-02-14 Jurgen Wachter Metal alloy for medical devices and implants
FR2851181B1 (en) 2003-02-17 2006-05-26 Commissariat Energie Atomique METHOD FOR COATING A SURFACE
US20050079199A1 (en) 2003-02-18 2005-04-14 Medtronic, Inc. Porous coatings for drug release from medical devices
EP1596895B1 (en) 2003-02-18 2009-02-04 Medtronic, Inc. Occlusion resistant hydrocephalic shunt
US20040167572A1 (en) 2003-02-20 2004-08-26 Roth Noah M. Coated medical devices
EP1449546B1 (en) 2003-02-21 2010-10-27 Sorin Biomedica Cardio S.R.L. A process for producing stents and corresponding stent
US7001421B2 (en) 2003-02-28 2006-02-21 Medtronic Vascular, Inc. Stent with phenoxy primer coating
US6699282B1 (en) 2003-03-06 2004-03-02 Gelsus Research And Consulting, Inc. Method and apparatus for delivery of medication
US6932930B2 (en) 2003-03-10 2005-08-23 Synecor, Llc Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same
US8281737B2 (en) 2003-03-10 2012-10-09 Boston Scientific Scimed, Inc. Coated medical device and method for manufacturing the same
US20040202692A1 (en) 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device and method for in situ selective modulation of agent delivery
US20050070996A1 (en) 2003-04-08 2005-03-31 Dinh Thomas Q. Drug-eluting stent for controlled drug delivery
US7163555B2 (en) 2003-04-08 2007-01-16 Medtronic Vascular, Inc. Drug-eluting stent for controlled drug delivery
US20060142853A1 (en) 2003-04-08 2006-06-29 Xingwu Wang Coated substrate assembly
US20050216075A1 (en) 2003-04-08 2005-09-29 Xingwu Wang Materials and devices of enhanced electromagnetic transparency
US20050107870A1 (en) 2003-04-08 2005-05-19 Xingwu Wang Medical device with multiple coating layers
KR20060010736A (en) 2003-04-14 2006-02-02 가오가부시끼가이샤 Cleaning agent composition
US20050038498A1 (en) 2003-04-17 2005-02-17 Nanosys, Inc. Medical device applications of nanostructured surfaces
US20050221072A1 (en) 2003-04-17 2005-10-06 Nanosys, Inc. Medical device applications of nanostructured surfaces
US20040215313A1 (en) 2003-04-22 2004-10-28 Peiwen Cheng Stent with sandwich type coating
US20040236399A1 (en) 2003-04-22 2004-11-25 Medtronic Vascular, Inc. Stent with improved surface adhesion
US20040230176A1 (en) 2003-04-23 2004-11-18 Medtronic Vascular, Inc. System for treating a vascular condition that inhibits restenosis at stent ends
US7482034B2 (en) 2003-04-24 2009-01-27 Boston Scientific Scimed, Inc. Expandable mask stent coating method
WO2004096176A2 (en) 2003-04-25 2004-11-11 Boston Scientific Scimed Inc. Solid drug formulation and device for storage and controlled delivery thereof
US7288084B2 (en) 2003-04-28 2007-10-30 Boston Scientific Scimed, Inc. Drug-loaded medical device
EP1633320A2 (en) 2003-05-02 2006-03-15 SurModics, Inc. Implantable controlled release bioactive agent delivery device
US8246974B2 (en) 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
US7279174B2 (en) 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
US20040230290A1 (en) 2003-05-15 2004-11-18 Jan Weber Medical devices and methods of making the same
US6846323B2 (en) 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
BRPI0410641A (en) 2003-05-16 2006-07-04 Blue Membranes Gmbh substrate coating process with carbon based material
US7524527B2 (en) 2003-05-19 2009-04-28 Boston Scientific Scimed, Inc. Electrostatic coating of a device
US20040236416A1 (en) 2003-05-20 2004-11-25 Robert Falotico Increased biocompatibility of implantable medical devices
US20050211680A1 (en) 2003-05-23 2005-09-29 Mingwei Li Systems and methods for laser texturing of surfaces of a substrate
US20030216803A1 (en) 2003-05-28 2003-11-20 Ledergerber Walter J. Textured and drug eluting stent-grafts
US7041127B2 (en) 2003-05-28 2006-05-09 Ledergerber Walter J Textured and drug eluting coronary artery stent
US7297644B2 (en) 2003-05-28 2007-11-20 Air Products Polymers, L.P. Nonwoven binders with high wet/dry tensile strength ratio
MXPA05011231A (en) 2003-05-28 2006-09-14 Soheil Asgari Implants comprising functionalized carbon surfaces
US7270679B2 (en) 2003-05-30 2007-09-18 Warsaw Orthopedic, Inc. Implants based on engineered metal matrix composite materials having enhanced imaging and wear resistance
US6904658B2 (en) 2003-06-02 2005-06-14 Electroformed Stents, Inc. Process for forming a porous drug delivery layer
US6979348B2 (en) 2003-06-04 2005-12-27 Medtronic Vascular, Inc. Reflowed drug-polymer coated stent and method thereof
JP4971580B2 (en) 2003-06-05 2012-07-11 テルモ株式会社 Stent and method for manufacturing stent
US7169179B2 (en) 2003-06-05 2007-01-30 Conor Medsystems, Inc. Drug delivery device and method for bi-directional drug delivery
TWI255580B (en) 2003-07-02 2006-05-21 Sony Corp MEMS type oscillator, process for fabricating the same, filter, and communication unit
EP1647020A1 (en) 2003-07-10 2006-04-19 Koninklijke Philips Electronics N.V. Embedding watermark for protecting multiple copies of a signal
US20050021127A1 (en) 2003-07-21 2005-01-27 Kawula Paul John Porous glass fused onto stent for drug retention
US20050021128A1 (en) 2003-07-24 2005-01-27 Medtronic Vascular, Inc. Compliant, porous, rolled stent
US7682603B2 (en) 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
US20050027350A1 (en) 2003-07-30 2005-02-03 Biotronik Mess-Und Therapiegeraete Gmbh & Co Ingenieurbuero Berlin Endovascular implant for the injection of an active substance into the media of a blood vessel
US7056591B1 (en) 2003-07-30 2006-06-06 Advanced Cardiovascular Systems, Inc. Hydrophobic biologically absorbable coatings for drug delivery devices and methods for fabricating the same
US20050033417A1 (en) 2003-07-31 2005-02-10 John Borges Coating for controlled release of a therapeutic agent
JPWO2005011796A1 (en) 2003-08-05 2006-09-14 株式会社カネカ Indwelling stent
US20050037047A1 (en) 2003-08-11 2005-02-17 Young-Ho Song Medical devices comprising spray dried microparticles
US20050055085A1 (en) 2003-09-04 2005-03-10 Rivron Nicolas C. Implantable medical devices having recesses
US20050055080A1 (en) 2003-09-05 2005-03-10 Naim Istephanous Modulated stents and methods of making the stents
US7494950B2 (en) 2003-09-05 2009-02-24 Synthes (U.S.A.) Bone cement compositions having fiber-reinforcement and/or increased flowability
US7488343B2 (en) 2003-09-16 2009-02-10 Boston Scientific Scimed, Inc. Medical devices
US20050060020A1 (en) 2003-09-17 2005-03-17 Scimed Life Systems, Inc. Covered stent with biologically active material
EP1677714A4 (en) 2003-09-18 2008-01-16 Advanced Bio Prothestic Surfac Medical device having mems functionality and methods of making same
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20050070990A1 (en) 2003-09-26 2005-03-31 Stinson Jonathan S. Medical devices and methods of making same
US7247166B2 (en) 2003-09-29 2007-07-24 Advanced Cardiovascular Systems, Inc. Intravascular stent with extendible end rings
US7055237B2 (en) 2003-09-29 2006-06-06 Medtronic Vascular, Inc. Method of forming a drug eluting stent
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US7618647B2 (en) 2003-10-03 2009-11-17 Boston Scientific Scimed, Inc. Using bucky paper as a therapeutic aid in medical applications
US7284677B2 (en) 2003-10-08 2007-10-23 Elizabeth Ann Guevara Bottle holding appliance and method for its use
WO2005039668A2 (en) 2003-10-21 2005-05-06 Boiarski Anthony A Implantable drug delivery device for sustained release of therapeutic agent
US20050087520A1 (en) 2003-10-28 2005-04-28 Lixiao Wang Method and apparatus for selective ablation of coatings from medical devices
FR2861740B1 (en) 2003-10-29 2005-12-16 Inst Rech Developpement Ird ATTENUATED VIRULENCE PROTOZOATIC STRAINS AND THEIR USE
US20050113936A1 (en) 2003-10-30 2005-05-26 Brustad John R. Surface treatments and modifications using nanostructure materials
GB0325647D0 (en) 2003-11-03 2003-12-10 Finsbury Dev Ltd Prosthetic implant
US7208172B2 (en) 2003-11-03 2007-04-24 Medlogics Device Corporation Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices
US7435256B2 (en) 2003-11-06 2008-10-14 Boston Scientific Scimed, Inc. Method and apparatus for controlled delivery of active substance
WO2005044361A1 (en) 2003-11-07 2005-05-19 Merlin Md Pte Ltd Implantable medical devices with enhanced visibility, mechanical properties and biocompatibility
US20050100577A1 (en) 2003-11-10 2005-05-12 Parker Theodore L. Expandable medical device with beneficial agent matrix formed by a multi solvent system
WO2005044142A2 (en) 2003-11-10 2005-05-19 Angiotech International Ag Intravascular devices and fibrosis-inducing agents
CA2545815A1 (en) 2003-11-14 2005-06-09 Genvec, Inc. Adenoviral vectored tnf-a and chemoradiation to treat cancer
US8435285B2 (en) 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
JP4610885B2 (en) 2003-11-28 2011-01-12 ゼオンメディカル株式会社 Cell growth suppression film and medical device
JP4512351B2 (en) 2003-11-28 2010-07-28 ゼオンメディカル株式会社 Gastrointestinal stent
US20050119723A1 (en) 2003-11-28 2005-06-02 Medlogics Device Corporation Medical device with porous surface containing bioerodable bioactive composites and related methods
US20060085062A1 (en) 2003-11-28 2006-04-20 Medlogics Device Corporation Implantable stent with endothelialization factor
WO2005051450A1 (en) 2003-11-28 2005-06-09 Zeon Medical, Inc. Cell growth-inhibiting film, medical instrument and stent for digestive organs
US20050131522A1 (en) 2003-12-10 2005-06-16 Stinson Jonathan S. Medical devices and methods of making the same
DE10358502B3 (en) 2003-12-13 2005-04-07 Daimlerchrysler Ag Production of a hollow profile used as a branched part for pipes comprises stamping a secondary molding element to connect to a further component in a pre-curved region before winding
US8017178B2 (en) 2003-12-16 2011-09-13 Cardiac Pacemakers, Inc. Coatings for implantable electrodes
US20050137677A1 (en) 2003-12-17 2005-06-23 Rush Scott L. Endovascular graft with differentiable porosity along its length
US20050137679A1 (en) 2003-12-17 2005-06-23 Pfizer Inc Modified stent useful for delivery of drugs along stent strut
WO2005063318A1 (en) 2003-12-17 2005-07-14 Pfizer Products Inc. Stent with therapeutically active drug coated thereon
US8652502B2 (en) 2003-12-19 2014-02-18 Cordis Corporation Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
US8043311B2 (en) 2003-12-22 2011-10-25 Boston Scientific Scimed, Inc. Medical device systems
US7563324B1 (en) 2003-12-29 2009-07-21 Advanced Cardiovascular Systems Inc. System and method for coating an implantable medical device
US7153411B2 (en) 2003-12-30 2006-12-26 Boston Scientific Scimed, Inc. Method for cleaning and polishing metallic alloys and articles cleaned or polished thereby
US20050159805A1 (en) 2004-01-20 2005-07-21 Jan Weber Functional coatings and designs for medical implants
WO2005070338A1 (en) 2004-01-20 2005-08-04 Cook Incorporated Multiple stitches for attaching stent to graft
US7854756B2 (en) 2004-01-22 2010-12-21 Boston Scientific Scimed, Inc. Medical devices
US7211108B2 (en) 2004-01-23 2007-05-01 Icon Medical Corp. Vascular grafts with amphiphilic block copolymer coatings
US7393589B2 (en) 2004-01-30 2008-07-01 Ionbond, Inc. Dual layer diffusion bonded chemical vapor coating for medical implants
ITTO20040056A1 (en) 2004-02-05 2004-05-05 Sorin Biomedica Cardio Spa STENT FOR THE ENDOLIMINAL DELIVERY OF PRINCIPLES OR ACTIVE AGENTS
US7442681B2 (en) 2004-02-10 2008-10-28 University Of Virginia Patent Foundation Method of inhibiting vascular permeability
US20050180919A1 (en) 2004-02-12 2005-08-18 Eugene Tedeschi Stent with radiopaque and encapsulant coatings
US8049137B2 (en) 2004-02-13 2011-11-01 Boston Scientific Scimed, Inc. Laser shock peening of medical devices
US7981441B2 (en) 2004-02-18 2011-07-19 The Board Of Trustees Of The Leland Stanford Junior University Drug delivery systems using mesoporous oxide films
US8097269B2 (en) 2004-02-18 2012-01-17 Celonova Biosciences, Inc. Bioactive material delivery systems comprising sol-gel compositions
US20050187608A1 (en) 2004-02-24 2005-08-25 O'hara Michael D. Radioprotective compound coating for medical devices
US8137397B2 (en) 2004-02-26 2012-03-20 Boston Scientific Scimed, Inc. Medical devices
US8591568B2 (en) 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US20050197687A1 (en) 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
FR2867059B1 (en) 2004-03-03 2006-05-26 Braun Medical ENDOPROTHESIS WITH MARKERS FOR CONDUCTING A LIVING BODY
US20050196518A1 (en) * 2004-03-03 2005-09-08 Stenzel Eric B. Method and system for making a coated medical device
US20050203606A1 (en) 2004-03-09 2005-09-15 Vancamp Daniel H. Stent system for preventing restenosis
JP5150895B2 (en) 2004-03-12 2013-02-27 国立大学法人長岡技術科学大学 Membrane electrode assembly, method for producing membrane electrode assembly, and polymer electrolyte fuel cell
US6979473B2 (en) 2004-03-15 2005-12-27 Boston Scientific Scimed, Inc. Method for fine bore orifice spray coating of medical devices and pre-filming atomization
US7744644B2 (en) 2004-03-19 2010-06-29 Boston Scientific Scimed, Inc. Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release
JP2007195883A (en) 2006-01-30 2007-08-09 Toyo Advanced Technologies Co Ltd Stent and its production method
KR20070116191A (en) 2004-03-30 2007-12-06 토요 어드밴스드 테크놀로지스 컴퍼니 리미티드 Method for treating surface of material, medical material, and medical instrument
US20050220853A1 (en) 2004-04-02 2005-10-06 Kinh-Luan Dao Controlled delivery of therapeutic agents from medical articles
CN1964748A (en) 2004-04-06 2007-05-16 苏莫迪克斯公司 Coating compositions for bioactive agents
US7635515B1 (en) 2004-04-08 2009-12-22 Powdermet, Inc Heterogeneous composite bodies with isolated lenticular shaped cermet regions
US20050228477A1 (en) 2004-04-09 2005-10-13 Xtent, Inc. Topographic coatings and coating methods for medical devices
US20050228491A1 (en) 2004-04-12 2005-10-13 Snyder Alan J Anti-adhesive surface treatments
US20050230039A1 (en) 2004-04-19 2005-10-20 Michael Austin Stent with protective pads or bulges
US20050251245A1 (en) 2004-05-05 2005-11-10 Karl Sieradzki Methods and apparatus with porous materials
US7955371B2 (en) 2004-05-12 2011-06-07 Medtronic Vascular, Inc. System and method for stent deployment and infusion of a therapeutic agent into tissue adjacent to the stent ends
US7758892B1 (en) 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices having multiple layers
US20060100696A1 (en) 2004-11-10 2006-05-11 Atanasoska Ljiljana L Medical devices and methods of making the same
US20050266039A1 (en) 2004-05-27 2005-12-01 Jan Weber Coated medical device and method for making the same
US20050266040A1 (en) 2004-05-28 2005-12-01 Brent Gerberding Medical devices composed of porous metallic materials for delivering biologically active materials
US7695775B2 (en) 2004-06-04 2010-04-13 Applied Microstructures, Inc. Controlled vapor deposition of biocompatible coatings over surface-treated substrates
KR20050117361A (en) 2004-06-10 2005-12-14 류용선 Titanium oxide coating stent and manufaturing method thereof
US7332101B2 (en) 2004-06-25 2008-02-19 Massachusetts Institute Of Technology Permanently linked, rigid, magnetic chains
US7078108B2 (en) 2004-07-14 2006-07-18 The Regents Of The University Of California Preparation of high-strength nanometer scale twinned coating and foil
US20060015361A1 (en) 2004-07-16 2006-01-19 Jurgen Sattler Method and system for customer contact reporting
US7144840B2 (en) 2004-07-22 2006-12-05 Hong Kong University Of Science And Technology TiO2 material and the coating methods thereof
CA2474367A1 (en) 2004-07-26 2006-01-26 Jingzeng Zhang Electrolytic jet plasma process and apparatus for cleaning, case hardening, coating and anodizing
US7269700B2 (en) 2004-07-26 2007-09-11 Integrated Device Technology, Inc. Status bus accessing only available quadrants during loop mode operation in a multi-queue first-in first-out memory system
US20060025848A1 (en) 2004-07-29 2006-02-02 Jan Weber Medical device having a coating layer with structural elements therein and method of making the same
US7601382B2 (en) * 2004-08-05 2009-10-13 Boston Scientific Scimed, Inc. Method of making a coated medical device
US20060034884A1 (en) 2004-08-10 2006-02-16 Stenzel Eric B Coated medical device having an increased coating surface area
EP1786363B1 (en) 2004-08-13 2010-04-14 Setagon, Inc. Methods for making medical devices having nanoporous layers
US20060275554A1 (en) 2004-08-23 2006-12-07 Zhibo Zhao High performance kinetic spray nozzle
US7507433B2 (en) 2004-09-03 2009-03-24 Boston Scientific Scimed, Inc. Method of coating a medical device using an electrowetting process
DE102004043232A1 (en) 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprosthesis made of magnesium alloy
DE102004043231A1 (en) 2004-09-07 2006-03-09 Biotronik Vi Patent Ag Endoprosthesis made of magnesium alloy
US7229471B2 (en) 2004-09-10 2007-06-12 Advanced Cardiovascular Systems, Inc. Compositions containing fast-leaching plasticizers for improved performance of medical devices
DE102004044738A1 (en) 2004-09-15 2006-03-16 Technische Universität München Process for producing a structuring of metal surfaces and components produced by this process
US7901451B2 (en) 2004-09-24 2011-03-08 Biosensors International Group, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20060075044A1 (en) 2004-09-30 2006-04-06 Fox Kevin D System and method for electronic contact list-based search and display
US20060075092A1 (en) 2004-10-06 2006-04-06 Kabushiki Kaisha Toshiba System and method for determining the status of users and devices from access log information
US7344560B2 (en) 2004-10-08 2008-03-18 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20060079863A1 (en) 2004-10-08 2006-04-13 Scimed Life Systems, Inc. Medical devices coated with diamond-like carbon
US20060085065A1 (en) 2004-10-15 2006-04-20 Krause Arthur A Stent with auxiliary treatment structure
US20060085058A1 (en) 2004-10-20 2006-04-20 Rosenthal Arthur L System and method for delivering a biologically active material to a body lumen
US7862835B2 (en) 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US20060088566A1 (en) 2004-10-27 2006-04-27 Scimed Life Systems, Inc.,A Corporation Method of controlling drug release from a coated medical device through the use of nucleating agents
CA2583911A1 (en) 2004-10-28 2006-05-11 Microchips, Inc. Orthopedic and dental implant devices providing controlled drug delivery
US20060093643A1 (en) 2004-11-04 2006-05-04 Stenzel Eric B Medical device for delivering therapeutic agents over different time periods
US7628807B2 (en) 2004-11-04 2009-12-08 Boston Scientific Scimed, Inc. Stent for delivering a therapeutic agent having increased body tissue contact surface
US20060122694A1 (en) 2004-12-03 2006-06-08 Stinson Jonathan S Medical devices and methods of making the same
GB0426841D0 (en) 2004-12-07 2005-01-12 Univ Brunel Medical implant
US20060129215A1 (en) 2004-12-09 2006-06-15 Helmus Michael N Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
US20060127442A1 (en) 2004-12-09 2006-06-15 Helmus Michael N Use of supercritical fluids to incorporate biologically active agents into nanoporous medical articles
US20060127443A1 (en) * 2004-12-09 2006-06-15 Helmus Michael N Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US20060125144A1 (en) 2004-12-14 2006-06-15 Jan Weber Stent and stent manufacturing methods
US20060129225A1 (en) 2004-12-15 2006-06-15 Kopia Gregory A Device for the delivery of a cardioprotective agent to ischemic reperfused myocardium
US7632307B2 (en) 2004-12-16 2009-12-15 Advanced Cardiovascular Systems, Inc. Abluminal, multilayer coating constructs for drug-delivery stents
DE102004062394B4 (en) 2004-12-23 2008-05-29 Siemens Ag Intravenous pacemaker electrode and process for its preparation
ES2693248T3 (en) 2004-12-24 2018-12-10 Hexacath Mechanical part with improved deformability
US20060140867A1 (en) 2004-12-28 2006-06-29 Helfer Jeffrey L Coated stent assembly and coating materials
US7727273B2 (en) 2005-01-13 2010-06-01 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20090177282A1 (en) 2005-01-14 2009-07-09 National Research Council Of Canada Implantable biomimetic prosthetic bone
US8057543B2 (en) 2005-01-28 2011-11-15 Greatbatch Ltd. Stent coating for eluting medication
US8535702B2 (en) 2005-02-01 2013-09-17 Boston Scientific Scimed, Inc. Medical devices having porous polymeric regions for controlled drug delivery and regulated biocompatibility
WO2006082221A1 (en) 2005-02-03 2006-08-10 Cinvention Ag Drug delivery materials made by sol/gel technology
US20070003589A1 (en) 2005-02-17 2007-01-04 Irina Astafieva Coatings for implantable medical devices containing attractants for endothelial cells
DE102005010100A1 (en) 2005-03-02 2006-09-14 Hehrlein, Friedrich Wilhelm, Prof. Dr. Dr. Medical instrument with an asymmetrical microcrater in outer surface and a medicament holding fatty acid layer useful in administration of slow release drugs, e.g. in angioplasty, where medicament fatty acid layer can be mxied with acetone
US20060200229A1 (en) 2005-03-03 2006-09-07 Robert Burgermeister Geometry and material for use in high strength, high flexibility, controlled recoil drug eluting stents
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US20060199876A1 (en) 2005-03-04 2006-09-07 The University Of British Columbia Bioceramic composite coatings and process for making same
US7837726B2 (en) 2005-03-14 2010-11-23 Abbott Laboratories Visible endoprosthesis
US20060229715A1 (en) 2005-03-29 2006-10-12 Sdgi Holdings, Inc. Implants incorporating nanotubes and methods for producing the same
US9125968B2 (en) 2005-03-30 2015-09-08 Boston Scientific Scimed, Inc. Polymeric/ceramic composite materials for use in medical devices
CA2603332C (en) 2005-03-31 2013-09-10 Conor Medsystems, Inc. System and method for loading a beneficial agent into a medical device
US7641983B2 (en) 2005-04-04 2010-01-05 Boston Scientific Scimed, Inc. Medical devices including composites
CN105030390A (en) 2005-04-05 2015-11-11 万能医药公司 Degradable implantable medical devices
US20060233941A1 (en) 2005-04-15 2006-10-19 Boston Scientific Scimed, Inc. Method of coating a medical device utilizing an ion-based thin film deposition technique, a system for coating a medical device, and a medical device produced by the method
US8734851B2 (en) 2005-04-29 2014-05-27 Wisconsin Alumni Research Foundation Localized delivery of nucleic acid by polyelectrolyte assemblies
WO2006125086A2 (en) 2005-05-19 2006-11-23 Isoflux, Inc. Multi-layer coating system and method
US20060276910A1 (en) 2005-06-01 2006-12-07 Jan Weber Endoprostheses
WO2006133223A2 (en) 2005-06-06 2006-12-14 Innovational Holdings, Llc Implantable medical device with openings for delivery of beneficial agents with combination release kinetics
US8273117B2 (en) 2005-06-22 2012-09-25 Integran Technologies Inc. Low texture, quasi-isotropic metallic stent
US7368065B2 (en) 2005-06-23 2008-05-06 Depuy Products, Inc. Implants with textured surface and methods for producing the same
US20070038176A1 (en) 2005-07-05 2007-02-15 Jan Weber Medical devices with machined layers for controlled communications with underlying regions
WO2007016961A1 (en) 2005-08-05 2007-02-15 Institut National De La Santé Et De La Recherche Médicale (Inserm) Materials useful for support and/or replacement of tissue and the use thereof for making prostheses
US7914809B2 (en) 2005-08-26 2011-03-29 Boston Scientific Scimed, Inc. Lubricious composites for medical devices
US20070048452A1 (en) 2005-09-01 2007-03-01 James Feng Apparatus and method for field-injection electrostatic spray coating of medical devices
EP1764116A1 (en) 2005-09-16 2007-03-21 Debiotech S.A. Porous coating process using colloidal particles
US20070073385A1 (en) 2005-09-20 2007-03-29 Cook Incorporated Eluting, implantable medical device
US20070065418A1 (en) 2005-09-20 2007-03-22 Franco Vallana Method and device for cellular therapy
US20070073390A1 (en) 2005-09-23 2007-03-29 Medlogics Device Corporation Methods and devices for enhanced adhesion between metallic substrates and bioactive material-containing coatings
US8008395B2 (en) 2005-09-27 2011-08-30 Boston Scientific Scimed, Inc. Organic-inorganic hybrid particle material and polymer compositions containing same
WO2007044229A2 (en) 2005-09-28 2007-04-19 Calcitec, Inc. Surface treatments for calcium phosphate-based implants
GB0522569D0 (en) 2005-11-04 2005-12-14 Univ Bath Biocompatible drug delivery device
DE102005053247A1 (en) 2005-11-08 2007-05-16 Martin Fricke Implant, in particular stent, and method for producing such an implant
US20070106347A1 (en) 2005-11-09 2007-05-10 Wun-Chen Lin Portable medical and cosmetic photon emission adjustment device and method using the same
US20070112421A1 (en) 2005-11-14 2007-05-17 O'brien Barry Medical device with a grooved surface
US7935379B2 (en) 2005-11-14 2011-05-03 Boston Scientific Scimed, Inc. Coated and imprinted medical devices and methods of making the same
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
US20070135908A1 (en) 2005-12-08 2007-06-14 Zhao Jonathon Z Absorbable stent comprising coating for controlling degradation and maintaining pH neutrality
US20070134288A1 (en) 2005-12-13 2007-06-14 Edward Parsonage Anti-adhesion agents for drug coatings
US7638156B1 (en) 2005-12-19 2009-12-29 Advanced Cardiovascular Systems, Inc. Apparatus and method for selectively coating a medical article
US20070148251A1 (en) 2005-12-22 2007-06-28 Hossainy Syed F A Nanoparticle releasing medical devices
US8834912B2 (en) 2005-12-30 2014-09-16 Boston Scientific Scimed, Inc. Medical devices having multiple charged layers
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US20070173923A1 (en) 2006-01-20 2007-07-26 Savage Douglas R Drug reservoir stent
US20070190104A1 (en) 2006-02-13 2007-08-16 Kamath Kalpana R Coating comprising an adhesive polymeric material for a medical device and method of preparing the same
US9526814B2 (en) 2006-02-16 2016-12-27 Boston Scientific Scimed, Inc. Medical balloons and methods of making the same
US20070191931A1 (en) 2006-02-16 2007-08-16 Jan Weber Bioerodible endoprostheses and methods of making the same
EP2292178A1 (en) 2006-02-28 2011-03-09 Straumann Holding AG Two-part implant
US8585753B2 (en) 2006-03-04 2013-11-19 John James Scanlon Fibrillated biodegradable prosthesis
DE102006010040B3 (en) 2006-03-04 2007-10-11 Eisenbau Krämer mbH straightener
US8597341B2 (en) 2006-03-06 2013-12-03 David Elmaleh Intravascular device with netting system
US20070212547A1 (en) 2006-03-08 2007-09-13 Boston Scientific Scimed, Inc. Method of powder coating medical devices
EP1834606B1 (en) 2006-03-16 2013-04-24 CID S.p.A. Stents
US20070224244A1 (en) 2006-03-22 2007-09-27 Jan Weber Corrosion resistant coatings for biodegradable metallic implants
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US7879086B2 (en) 2006-04-20 2011-02-01 Boston Scientific Scimed, Inc. Medical device having a coating comprising an adhesion promoter
US9155646B2 (en) 2006-04-27 2015-10-13 Brs Holdings, Llc Composite stent with bioremovable ceramic flakes
US20070254091A1 (en) 2006-04-28 2007-11-01 Boston Scientific Scimed, Inc. System and method for electrostatic-assisted spray coating of a medical device
US20070264303A1 (en) 2006-05-12 2007-11-15 Liliana Atanasoska Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent
EP1891988A1 (en) 2006-08-07 2008-02-27 Debiotech S.A. Anisotropic nanoporous coatings for medical implants
US8092818B2 (en) 2006-05-17 2012-01-10 Boston Scientific Scimed, Inc. Medical devices having bioactive surfaces
DE602007002407D1 (en) 2006-05-17 2009-10-22 Debiotech Sa ANISOTROPE NANOPOROUS COATINGS FOR MEDICAL IMPLANTS
WO2007143433A1 (en) 2006-05-31 2007-12-13 Setagon, Inc. Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
US8778376B2 (en) 2006-06-09 2014-07-15 Advanced Cardiovascular Systems, Inc. Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
GB0612028D0 (en) 2006-06-16 2006-07-26 Imp Innovations Ltd Bioactive glass
CA2655539A1 (en) 2006-06-21 2007-12-27 The University Of British Columbia Calcium phosphate coated implantable medical devices, and electrochemical deposition processes for making same
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2008002778A2 (en) 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
US20080008654A1 (en) 2006-07-07 2008-01-10 Boston Scientific Scimed, Inc. Medical devices having a temporary radiopaque coating
CN101588826A (en) 2006-08-02 2009-11-25 英孚拉玛特公司 Lumen-supporting devices and methods of making and using
WO2008016712A2 (en) 2006-08-02 2008-02-07 Inframat Corporation Medical devices and methods of making and using
US20080058921A1 (en) 2006-08-09 2008-03-06 Lindquist Jeffrey S Improved adhesion of a polymeric coating of a drug eluting stent
US20080057102A1 (en) 2006-08-21 2008-03-06 Wouter Roorda Methods of manufacturing medical devices for controlled drug release
US20080050413A1 (en) 2006-08-23 2008-02-28 Ronald Adrianus Maria Horvers Medical stent provided with a combination of melatonin and paclitaxel
US20080051881A1 (en) 2006-08-24 2008-02-28 Feng James Q Medical devices comprising porous layers for the release of therapeutic agents
US20080050415A1 (en) 2006-08-25 2008-02-28 Boston Scientic Scimed, Inc. Polymeric/ceramic composite materials for use in medical devices
DE102006041023B4 (en) 2006-09-01 2014-06-12 Biocer Entwicklungs Gmbh Structured coatings for implants and process for their preparation
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having drug-eluting film
WO2008034007A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices
CA2663303A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Endoprosthesis with adjustable surface features
US20080071353A1 (en) 2006-09-15 2008-03-20 Boston Scientific Scimed, Inc. Endoprosthesis containing magnetic induction particles
ES2368125T3 (en) 2006-09-15 2011-11-14 Boston Scientific Scimed, Inc. BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS.
CA2663212A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Magnetized bioerodible endoprosthesis
CA2663745A1 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Medical devices
WO2008036548A2 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
JP2010503486A (en) 2006-09-18 2010-02-04 ボストン サイエンティフィック リミテッド Endoprosthesis
EP2084310A1 (en) 2006-10-05 2009-08-05 Boston Scientific Limited Polymer-free coatings for medical devices formed by plasma electrolytic deposition
US8394488B2 (en) 2006-10-06 2013-03-12 Cordis Corporation Bioabsorbable device having composite structure for accelerating degradation
US20080097577A1 (en) 2006-10-20 2008-04-24 Boston Scientific Scimed, Inc. Medical device hydrogen surface treatment by electrochemical reduction
EP2088971A2 (en) 2006-11-03 2009-08-19 Boston Scientific Scimed, Inc. Ion bombardment of medical devices
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US20080294236A1 (en) 2007-05-23 2008-11-27 Boston Scientific Scimed, Inc. Endoprosthesis with Select Ceramic and Polymer Coatings
JP2010508999A (en) 2006-11-09 2010-03-25 ボストン サイエンティフィック リミテッド Endoprosthesis with coating
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
CN101199873B (en) 2006-12-14 2013-06-19 乐普(北京)医疗器械股份有限公司 Medicament elution instrument nanometer class colon washer machineole drug releasing structure and preparing method thereof
US7939095B2 (en) 2006-12-21 2011-05-10 Cordis Corporation Crosslinked silane coating for medical devices
EP2114480B1 (en) 2006-12-28 2016-01-06 Boston Scientific Limited Medical devices and methods of making the same
US20080171929A1 (en) 2007-01-11 2008-07-17 Katims Jefferson J Method for standardizing spacing between electrodes, and medical tape electrodes
CA2675633A1 (en) 2007-01-26 2008-07-31 Boston Scientific Limited Implantable medical endoprostheses
US7575593B2 (en) 2007-01-30 2009-08-18 Medtronic Vascular, Inc. Implantable device with reservoirs for increased drug loading
US8187255B2 (en) 2007-02-02 2012-05-29 Boston Scientific Scimed, Inc. Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
WO2008113005A2 (en) 2007-03-15 2008-09-18 Boston Scientific Scimed, Inc. Methods to improve the stability of cellular adhesive proteins and peptides
US20080243240A1 (en) 2007-03-26 2008-10-02 Medtronic Vascular, Inc. Biodegradable Metal Barrier Layer for a Drug-Eluting Stent
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US20080249600A1 (en) 2007-04-06 2008-10-09 Boston Scientific Scimed, Inc. Stents with drug reservoir layer and methods of making and using the same
WO2008124114A2 (en) 2007-04-09 2008-10-16 Boston Scientific Limited Stent with unconnected stent segments
JP2010524653A (en) 2007-04-25 2010-07-22 ボストン サイエンティフィック サイムド,インコーポレイテッド Medical device for therapeutic drug release and method of manufacturing the same
US20080275543A1 (en) 2007-05-02 2008-11-06 Boston Scientific Scimed, Inc. Stent
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US7888719B2 (en) 2007-05-23 2011-02-15 Taiwan Semiconductor Manufacturing Co., Ltd. Semiconductor memory structures
US20080306584A1 (en) 2007-06-05 2008-12-11 Pamela Kramer-Brown Implantable medical devices for local and regional treatment
US7901452B2 (en) 2007-06-27 2011-03-08 Abbott Cardiovascular Systems Inc. Method to fabricate a stent having selected morphology to reduce restenosis
WO2009009357A2 (en) 2007-07-06 2009-01-15 Boston Scientific Scimed, Inc. Implantable medical devices having adjustable pore volume and methods for making the same
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090018644A1 (en) 2007-07-13 2009-01-15 Jan Weber Boron-Enhanced Shape Memory Endoprostheses
EP2187988B1 (en) 2007-07-19 2013-08-21 Boston Scientific Limited Endoprosthesis having a non-fouling surface
US20090028785A1 (en) 2007-07-23 2009-01-29 Boston Scientific Scimed, Inc. Medical devices with coatings for delivery of a therapeutic agent
US20090157172A1 (en) 2007-07-24 2009-06-18 Boston Scientific Scrimed, Inc. Stents with polymer-free coatings for delivering a therapeutic agent
US20090030504A1 (en) 2007-07-27 2009-01-29 Boston Scientific Scimed, Inc. Medical devices comprising porous inorganic fibers for the release of therapeutic agents
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
WO2009020520A1 (en) 2007-08-03 2009-02-12 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US9248219B2 (en) 2007-09-14 2016-02-02 Boston Scientific Scimed, Inc. Medical devices having bioerodable layers for the release of therapeutic agents
US20100233226A1 (en) 2007-10-15 2010-09-16 Université Catholique de Louvain Drug-eluting nanowire array
US20090118812A1 (en) 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090118823A1 (en) 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis with porous reservoir
US20090118821A1 (en) 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis with porous reservoir and non-polymer diffusion layer
JP2011502577A (en) 2007-11-02 2011-01-27 ボストン サイエンティフィック リミテッド Degradable endoprosthesis
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US20090118813A1 (en) 2007-11-02 2009-05-07 Torsten Scheuermann Nano-patterned implant surfaces
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US20090118818A1 (en) 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Endoprosthesis with coating
US20090118809A1 (en) 2007-11-02 2009-05-07 Torsten Scheuermann Endoprosthesis with porous reservoir and non-polymer diffusion layer
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US20090118815A1 (en) 2007-11-02 2009-05-07 Boston Scientific Scimed, Inc. Stent
WO2009076592A2 (en) 2007-12-12 2009-06-18 Boston Scientific Scimed, Inc. Medical devices having porous component for controlled diffusion
US20100008970A1 (en) 2007-12-14 2010-01-14 Boston Scientific Scimed, Inc. Drug-Eluting Endoprosthesis
US7722661B2 (en) 2007-12-19 2010-05-25 Boston Scientific Scimed, Inc. Stent
US8303650B2 (en) 2008-01-10 2012-11-06 Telesis Research, Llc Biodegradable self-expanding drug-eluting prosthesis
US20090186068A1 (en) 2008-01-18 2009-07-23 Chameleon Scientific Corporation Atomic plasma deposited coatings for drug release
CN101978472B (en) 2008-01-18 2012-12-26 纳米表面技术有限责任公司 Nanofilm protective and release matrices
ES2371380T3 (en) 2008-01-24 2011-12-30 Boston Scientific Scimed, Inc. STENT TO SUPPLY A THERAPEUTIC AGENT FROM A SIDE SURFACE OF A STENT STEM.
WO2009102787A2 (en) 2008-02-12 2009-08-20 Boston Scientific Scimed, Inc. Medical implants with polysaccharide drug eluting coatings
US20100042206A1 (en) 2008-03-04 2010-02-18 Icon Medical Corp. Bioabsorbable coatings for medical devices
WO2009126766A2 (en) 2008-04-10 2009-10-15 Boston Scientific Scimed, Inc. Medical devices with an interlocking coating and methods of making the same
WO2009131911A2 (en) 2008-04-22 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US20090287301A1 (en) 2008-05-16 2009-11-19 Boston Scientific, Scimed Inc. Coating for medical implants
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
EP2303350A2 (en) 2008-06-18 2011-04-06 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8242037B2 (en) 2008-07-24 2012-08-14 The Regents Of The University Of Michigan Method of pressureless sintering production of densified ceramic composites
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
WO2010014690A2 (en) 2008-07-31 2010-02-04 Boston Scientific Scimed, Inc. Medical devices for therapeutic agent delivery
CN102196826A (en) 2008-08-27 2011-09-21 波士顿科学医学有限公司 Medical devices having inorganic coatings for therapeutic agent delivery
JP2010063768A (en) 2008-09-12 2010-03-25 Fujifilm Corp Stent having porous film and method of manufacturing the same
JP2012501806A (en) 2008-09-12 2012-01-26 ボストン サイエンティフィック サイムド,インコーポレイテッド Stent layer manufacturing of stents
US20100070013A1 (en) 2008-09-18 2010-03-18 Medtronic Vascular, Inc. Medical Device With Microsphere Drug Delivery System
US9283304B2 (en) 2008-11-25 2016-03-15 CARDINAL HEALTH SWITZERLAND 515 GmbH Absorbable stent having a coating for controlling degradation of the stent and maintaining pH neutrality

Also Published As

Publication number Publication date
US20080003251A1 (en) 2008-01-03
EP2051750A2 (en) 2009-04-29
JP2009542326A (en) 2009-12-03
WO2008002586A2 (en) 2008-01-03
WO2008002586A3 (en) 2008-05-29
EP2051750B1 (en) 2017-03-01
US20120323308A1 (en) 2012-12-20
US8815275B2 (en) 2014-08-26
JP5185263B2 (en) 2013-04-17

Similar Documents

Publication Publication Date Title
US8815275B2 (en) Coatings for medical devices comprising a therapeutic agent and a metallic material
US8187620B2 (en) Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8070797B2 (en) Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) Coated medical devices for abluminal drug delivery
US7879086B2 (en) Medical device having a coating comprising an adhesion promoter
US8900292B2 (en) Coating for medical device having increased surface area
JP2011509809A (en) Stent for delivering therapeutic agent from side surface of stent strut
WO2009014692A1 (en) Stents with polymer-free coatings for delivering a therapeutic agent
EP2182997A2 (en) Medical devices with coatings for delivery of a therapeutic agent
EP2125066A2 (en) Stent with a coating for delivering a therapeutic agent
US20090062910A1 (en) Stent with differential timing of abluminal and luminal release of a therapeutic agent
US20080215136A1 (en) Differential drug release from a medical device

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20130626